US20140288389A1 - Systems and Methods for Performing Neurophysiologic Assessments with Pressure Monitoring - Google Patents

Systems and Methods for Performing Neurophysiologic Assessments with Pressure Monitoring Download PDF

Info

Publication number
US20140288389A1
US20140288389A1 US14/294,304 US201414294304A US2014288389A1 US 20140288389 A1 US20140288389 A1 US 20140288389A1 US 201414294304 A US201414294304 A US 201414294304A US 2014288389 A1 US2014288389 A1 US 2014288389A1
Authority
US
United States
Prior art keywords
nerve
stimulation
pressure
retractor
retraction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US14/294,304
Inventor
James E. Gharib
Allen Farquhar
Scot Martinelli
David Ivanko
Benjamin Verhage
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nuvasive Inc
Original Assignee
Nuvasive Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nuvasive Inc filed Critical Nuvasive Inc
Priority to US14/294,304 priority Critical patent/US20140288389A1/en
Assigned to NUVASIVE, INC. reassignment NUVASIVE, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: FARQUHAR, ALLEN, MARTINELLI, SCOT, GHARIB, JAMES, IVANKO, DAVID, VERHAGE, BENJAMIN
Publication of US20140288389A1 publication Critical patent/US20140288389A1/en
Assigned to BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT reassignment BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Assignors: Impulse Monitoring, Inc., NUVASIVE, INC.
Assigned to BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT reassignment BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Assignors: BIOTRONIC NATIONAL, LLC, NUVASIVE CLINICAL SERVICES MONITORING, INC., NUVASIVE CLINICAL SERVICES, INC., NUVASIVE SPECIALIZED ORTHOPEDICS, INC., NUVASIVE, INC.
Assigned to BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT reassignment BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: NUVASIVE CLINICAL SERVICES MONITORING, INC., NUVASIVE CLINICAL SERVICES, INC., NUVASIVE SPECIALIZED ORTHOPEDICS, INC., NUVASIVE, INC.
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316Modalities, i.e. specific diagnostic methods
    • A61B5/389Electromyography [EMG]
    • A61B5/395Details of stimulation, e.g. nerve stimulation to elicit EMG response
    • A61B5/04001
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/05Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316Modalities, i.e. specific diagnostic methods
    • A61B5/388Nerve conduction study, e.g. detecting action potential of peripheral nerves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316Modalities, i.e. specific diagnostic methods
    • A61B5/389Electromyography [EMG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/40Detecting, measuring or recording for evaluating the nervous system
    • A61B5/4029Detecting, measuring or recording for evaluating the nervous system for evaluating the peripheral nervous systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/48Other medical applications
    • A61B5/4887Locating particular structures in or on the body
    • A61B5/4893Nerves

Definitions

  • the present invention relates to a system and methods generally aimed at surgery. More particularly, the present invention is directed at a system and related methods for performing neurophysiologic assessments with additional pressure monitoring.
  • spine surgery may provide great benefit to the patient, often allowing patients to resume activities long since abandoned because of the debilitating pain.
  • Spine surgery is not without risk.
  • Operating on or near the spine generally means operating in close proximity to delicate neural tissue, such as the spinal cord and nerve roots.
  • delicate nerve tissue Often, in order to reach the surgical target site the delicate nerve tissue must be retracted out of the surgical corridor.
  • a typical nerve retractor serves to pull or otherwise maintain the nerve outside the area of surgery, thereby protecting the nerve from inadvertent damage or contact by the “active” instrumentation used to perform the actual surgery. While generally advantageous in protecting the nerve, it has been observed that such retraction can cause nerve function to become impaired or otherwise pathologic over time due to the retraction. In certain surgical applications, such as spinal surgery, it is not possible to determine if such retraction is hurting or damaging the retracted nerve until after the surgery (generally referred to as a change in “nerve health” or “nerve status”).
  • the present invention is directed at eliminating, or at least reducing the effects of, the above-described problems.
  • the present invention includes a system and methods capable of performing a variety of neurophysiologic assessments, and particularly nerve pathology monitoring (via Nerve Retractor mode), by combining neurophysiology monitoring with any of a variety of instruments used in or in preparation for surgery (referred to herein as “surgical accessories”).
  • Other assessments performed by the system 10 may include one or more of, but not necessarily limited to, neuromuscular pathway status (Twitch Test), pedicle integrity testing (Screw Test), nerve proximity testing during surgical access (Detection), nerve pathology monitoring (Nerve Retractor), and detection of spontaneous muscle activity (Free Run EMG-which may be conducted alone or in conjunction with any other assessment).
  • the nerve pathology monitoring of the present invention may be augmented by equipping a nerve root retractor with one or more pressure sensing technologies and/or providing an additional system or device for assessing or monitoring the pressure being exerted upon a nerve or nerve root before, during and/or after nerve retraction.
  • the fundamental method steps for performing the nerve pathology assessments include: (a) stimulating one or more nerves with the surgical accessory (e.g. nerve retractor among others); (b) measuring the response of nerves innervated by the stimulation of step (a); (c) determining a relationship between the surgical accessory and the nerve based upon the response measured in step (b); and (d) communicating this relationship to the surgeon in an easy-to-interpret fashion.
  • the surgical accessory e.g. nerve retractor among others
  • the step of stimulating one or more nerves may be accomplished by applying any of a variety of suitable stimulation signals to an electrode(s) on the surgical accessory, including voltage and/or current pulses of varying magnitude and/or frequency.
  • the stimulating step may be performed at different times depending upon the particular surgical accessory in question. For example, with regard to neural pathology monitoring, stimulation may be performed before, during and/or after retraction of the nerve root, regardless of whether additional pressure sensing features for monitoring the pressure being exerted upon a retracted nerve or nerve root are employed.
  • the step of measuring the response of nerves innervated by the stimulation step may be performed in any number of suitable fashions, including but not limited to the use of evoked muscle action potential (EMAP) monitoring techniques (that is, measuring the EMG responses of muscle groups associated with a particular nerve).
  • EMG evoked muscle action potential
  • the measuring step is preferably accomplished via monitoring or measuring the EMG responses of the muscles innervated by the stimulated nerve(s).
  • the step of determining a relationship between the surgical accessory and the nerve based upon the measurement step may be performed in any number of suitable fashions depending upon the manner of measuring the response, and may define the relationship in any of a variety of fashions (based on any number of suitable parameters and/or characteristics).
  • the relationship may be, by way of example only, whether the neurophysiologic response of the nerve has changed over time. Such changes may be quickly determined using a hunting algorithm to determine a stimulation threshold current level at various times during the procedure.
  • these parameters may be augmented with information regarding the pressure being exerted upon a retracted nerve or nerve root.
  • the step of communicating this relationship to the surgeon in an easy-to-interpret fashion may be accomplished in any number of suitable fashions, including but not limited to the use of visual indicia (such as alpha-numeric characters, light-emitting elements, and/or graphics) and audio communications (such as a speaker element).
  • visual indicia such as alpha-numeric characters, light-emitting elements, and/or graphics
  • audio communications such as a speaker element.
  • the determined threshold value may be visually displayed as a simple numerical value on the display.
  • color coded graphics may be displayed to indicate the relative safety level indicated by the threshold value.
  • the step of communicating the relationship to the user may also include information about the pressure being exerted upon a retracted nerve or nerve root, such as the retraction duration, the extent of retraction, and/or the resulting pressure.
  • the nerve pathology monitoring function of the present invention may be augmented with additional pressure sensing capabilities. This may be accomplished by positioning one or more pressure sensors on the nerve retractor and communicatively linking the pressure sensor to pressure mapping software on the control unit or other processor.
  • FIG. 1 is a flow chart illustrating the fundamental steps of the neurophysiology-based surgical system according to the present invention
  • FIG. 2 is a perspective view of an exemplary system 10 capable of performing neurophysiologic assessments such as for example, detecting pedicle breaches, nerve proximity (detection), nerve pathology, neuromuscular pathway status, and spinal cord health.
  • neurophysiologic assessments such as for example, detecting pedicle breaches, nerve proximity (detection), nerve pathology, neuromuscular pathway status, and spinal cord health.
  • FIG. 3 is a block diagram of the system 10 shown in FIG. 2 ;
  • FIG. 4 is a graph illustrating an exemplary single pulse stimulation signal according to one embodiment of the present invention.
  • FIG. 5 is a is a graph illustrating an exemplary multipulse stimulation signal according to one embodiment of the present invention.
  • FIG. 6 is a graph illustrating an exemplary EMG response to the stimulus of FIG. 3 or 4 ;
  • FIG. 7 is a graph illustrating a plot of peak-to-peak voltage (Vpp) for each given stimulation current level (I Stim ) forming a stimulation current pulse train according to the present invention (otherwise known as a “recruitment curve”);
  • FIGS. 8-9 are perspective and side views, respectively, of an exemplary nerve root retractor assembly according to one embodiment of the present invention.
  • FIG. 10 is a perspective view of an exemplary nerve root retractor forming part of the assembly of FIGS. 8 and 9 , according to one embodiment of the present invention.
  • FIG. 11 is an exemplary screen display illustrating one embodiment of the Nerve Retractor mode for performing neural pathology monitoring according to one embodiment of the present invention
  • FIG. 12 is a perspective view of an exemplary nerve root retractor including a pressure sensor according to one embodiment of the present invention.
  • FIG. 13 is a perspective view of the system of FIG. 2 adapted to perform additional pressure sensing functions according to one embodiment of the present invention
  • FIG. 14 is an exemplary multi-function screen display of the pressure sensing features of the system 10 according to one embodiment of the present invention.
  • FIG. 15 is an exemplary full screen display of the 2-dimensional pressure mapping feature according to one embodiment of the present invention.
  • FIG. 16 is an exemplary full screen display of the 3-dimensional pressure mapping feature according to one embodiment of the present invention.
  • FIG. 17 is an exemplary full screen display of the pressure distribution chart feature according to one embodiment of the present invention.
  • FIG. 18 is an exemplary full screen display of the pressure vs. time chart feature according to one embodiment of the present invention.
  • FIG. 19 is a perspective view of the system of FIG. 2 adapted to perform additional pressure sensing functions according to a different embodiment of the present invention.
  • FIG. 20 is an exemplary screen display illustrating one embodiment of the Nerve Retractor mode for performing neural pathology monitoring augmented by pressure monitoring according to one embodiment of the present invention.
  • the present invention is capable of performing a variety of neurophysiologic assessments, and particularly nerve pathology monitoring (via Nerve Retractor mode), by combining neurophysiology monitoring with any of a variety of instruments used in or in preparation for surgery (referred to herein as “surgical accessories”).
  • Other assessments performed by the system 10 may include one or more of, but not necessarily limited to, neuromuscular pathway status (Twitch Test), pedicle integrity testing (Screw Test), nerve proximity testing during surgical access (Detection), and detection of spontaneous muscle activity (Free Run EMG—which may be conducted alone or in conjunction with any other mode).
  • the nerve pathology monitoring of the present invention may be augmented by equipping a nerve root retractor 29 with one or more pressure sensing technologies and/or providing an additional system or device for assessing or monitoring the pressure being exerted upon a nerve or nerve root before, during and/or after nerve retraction. It is expressly noted that, although described herein largely in terms of use in spinal surgery, the neuromonitoring system 10 and related methods of the present invention are suitable for use in any number of additional surgical procedures where neurological impairment due to nerve retraction is a concern.
  • FIG. 1 illustrates the fundamental method steps for performing the nerve pathology assessments (as well as many of the other assessments which may be performed) according to the present invention, namely: (a) stimulating one or more nerves with the surgical accessory (e.g. nerve retactor); (b) measuring the response of nerves innervated by the stimulation of step (a); (c) determining a relationship between the surgical accessory and the nerve based upon the response measured in step (b); and (d) communicating this relationship to the surgeon in an easy-to-interpret fashion.
  • the surgical accessory e.g. nerve retactor
  • FIGS. 2-3 illustrate, by way of example only, a surgical system 10 provided in accordance with a broad aspect of the present invention.
  • the surgical system 10 includes a control unit 12 , a patient module 14 , an EMG harness 16 including 8 pairs of EMG electrodes 18 and a return electrode 22 coupled to the patient module 14 , and a host of surgical accessories 24 capable of being coupled to the patient module 14 via one or more accessory cables 26 .
  • the surgical accessories 24 include (by way of example only) a screw test assembly 27 and a nerve root retractor assembly 28 .
  • Other surgical accessories not shown here may include, but are not necessarily limited to, a K-wire, a sequential dilation access system (e.g.
  • an MEP stimulator (not shown) may also be connected to the system 10 .
  • the control unit 12 includes a touch screen display 30 and a base 32 , which collectively contain the essential processing capabilities for controlling the surgical system 10 .
  • the patient module 14 is connected to the control unit 12 via a data cable 34 (or optionally via wireless communication), which establishes the electrical connections and communications (digital and/or analog) between the control unit 12 and patient module 14 .
  • the main functions of the control unit 12 include receiving user commands via the touch screen display 30 , activating stimulation in the selected mode (e.g. Nerve Retractor), processing signal data according to defined algorithms (described below), displaying received parameters and processed data, and monitoring system status and reporting fault conditions.
  • the touch screen display 30 is preferably equipped with a graphical user interface (GUI) capable of communicating information to the user and receiving instructions from the user.
  • GUI graphical user interface
  • the display 30 and/or base 32 may contain patient module interface circuitry that commands the stimulation sources, receives digitized signals and other information from the patient module 14 , processes the EMG responses to extract characteristic information for each muscle group, and displays the processed data to the operator via the display 30 .
  • the step (a) of stimulating one or more target tissues with the surgical accessory 24 is accomplished be coupling one or more surgical accessories 24 equipped with an electrode region(s) to a stimulation source (e.g. the patient module) communicatively linked to the control unit 12 .
  • a stimulation source e.g. the patient module
  • multiple coupling options are included with the system 10 to accommodate the variety of surgical accessories and functions performed by the system 10 .
  • a stimulation handpiece 36 FIG. 1
  • the stimulation handpiece 36 may include one or more buttons 38 for selectively initiating stimulation according to the selected function.
  • the stimulation handpiece 36 is reusable and sterilizable.
  • an electric coupling device such as, by way of example only, stimulation clip 40 and/or stimulation clip 42 ( FIG. 1 ) may be provided to couple surgical accessories 24 (such as for example, a tap member, access probe, tissue retractor assembly, and/or various cannulae) to the system 10 such that stimulation signals may be transmitted through the tool during use.
  • the electric coupling device may be used alone or using in conjunction with stimulation handpiece 36 , as is shown.
  • Various other connectors may also be employed to couple the surgical accessory to the stimulation source, such as for example, a male/female type socket connection and other commonly know electrical connectors.
  • the step (b) of measuring the response of nerves innervated by the stimulation of step (a) may be performed in any number of suitable fashions, including but not limited to the use of evoked muscle action potential (EMAP) monitoring techniques (that is, measuring the EMG responses of muscle groups associated with a particular nerve).
  • EMG response monitoring is accomplished via 8 pairs EMG electrodes 18 (placed on the skin over the muscle groups to be monitored), a common electrode 20 providing a ground reference to pre-amplifiers in the patient module 14 , and an anode electrode 22 providing a return path for the stimulation current.
  • a preferred EMG electrode for use with the system 10 is a dual surface electrode which is shown and described in detail in the commonly owned and co-pending U.S. patent application Ser. No.
  • EMG electrode placement depends on a multitude of factors, including for example, the spinal cord level and particular nerves at risk and user preference, among others. In one embodiment (set forth by way of example only), the preferred EMG configuration is described for Lumbar surgery in Table 1, Thoracolumbar surgery in Table 2, and Cervical surgery in Table 3 below:
  • the step (c) of determining a relationship between the surgical accessory and the nerve based upon the response measured in step (b) may be performed in any number of suitable fashions depending upon the manner of measuring the response, and may define the relationship in any of a variety of fashions based on any number of suitable parameters and/or characteristics).
  • the step of determining a relationship within the context of a nerve pathology assessment, may involve identifying what stimulation current level is required to evoke a significant muscle response (i.e. the relationship between the surgical accessory (and more specifically the stimulation signal emitted from the surgical accessory) and the nerve may be defined as the stimulation threshold current level, described below).
  • a significant EMG response is defined as having a V pp of approximately 100 uV.
  • the lowest stimulation signal current, I stim that evokes this threshold voltage (V Thresh ) is called I Thresh .
  • Finding I thresh is useful in making neurophysiologic assessments because it provides a relative indication as to the degree of communication between a stimulation signal and nerve tissue. For example, as the degree of electrical communication between a stimulation signal and a nerve decreases, I thresh will increase. Conversely, as the degree of communication between the stimulation signal and a nerve increases, I thresh will decrease.
  • the system 10 capitalizes on and enhances the information derived from I thresh by quickly, accurately, and efficiently finding I thresh and comparing the determined value against predetermined safety indicator levels.
  • the surgeon may detect early on any problem or potential problem and then act to avoid and/or mitigate the situation.
  • an excessively high I thresh or an increase over a previous I thresh measurement during Nerve Retractor mode may indicate a deterioration of nerve root function caused by excessive and/or prolonged retraction.
  • a decrease in Ithresh over previous measurements may indicate During Screw Test and Detection modes, a low I thresh value may indicate a breach in the pedicle, or the close proximity of a nerve, respectively.
  • the system 10 may employ a variety of suitable algorithms and techniques which are described in detail in the “NeuroVision Applications,” all of which are incorporated by reference below, as if they were set forth herein in their entireties.
  • One exemplary threshold hunting algorithm is described hereafter in only brief detail.
  • the threshold hunting algorithm utilizes a bracketing method and a bisection method to find I thresh .
  • the bracketing method finds a range (bracket) of stimulation currents that must contain I thresh .
  • the algorithm directs stimulation to begin at a predetermined current level (based on the selected function). For each subsequent stimulation, the current level is doubled from the previous current level.
  • V thresh e.g. 100 uV.
  • the initial bracket is successively reduced via the bisection method to a predetermined width. This is accomplished by applying a first bisection stimulation current that bisects (i.e. forms the midpoint of) the initial bracket. If this first bisection stimulation current recruits, the bracket is reduced to the lower half of the initial bracket. If this first bisection stimulation current does not recruit, the bracket is reduced to the upper half of the initial bracket. This process is continued for each successive bracket until I thresh is bracketed by stimulation currents separated by the predetermined width.
  • the midpoint of this final bracket may be defined as I thresh ; however, any value falling within the final bracket may be selected as I thresh without departing from the scope of the present invention.
  • stimulations may stop after I thresh is determined for the channel possessing the lowest I thresh .
  • functions e.g. Screw Tests and Detection
  • the hunting algorithm may employ additional methods allowing it to omit certain stimulations, thereby reducing the number of stimulations and time required to obtain an I thresh value on each channel. I thresh is still found using the bracketing and bisection methods described above, however the algorithm will omit stimulations for which the result is predictable from data previously acquired. When a stimulation signal is omitted, the algorithm proceeds as if the stimulation had taken place.
  • the algorithm may confirm previously obtained I thresh values (e.g. by stimulation at current levels just below and at/or just above I thresh and determining whether the resulting responses are consistent with the previously acquired I thresh value), rather than initiating stimulations from the beginning each time a function is performed.
  • the final step (d) of communicating this relationship to the surgeon in an easy-to-interpret fashion may be accomplished in any number of suitable fashions, including but not limited to the use of visual indicia (such as alpha-numeric characters, light-emitting elements, and/or graphics) and audio communications (such as a speaker element).
  • visual indicia such as alpha-numeric characters, light-emitting elements, and/or graphics
  • audio communications such as a speaker element
  • the determined I thresh value may be visually displayed as a simple numerical value on display 30 .
  • color coded graphics may be displayed to indicate the relative safety level indicated by the I thresh (e.g.
  • the step of communicating the relationship to the user may also include information about the pressure being exerted upon a retracted nerve or nerve root, such as the retraction duration, the extent of retraction, and/or the resulting pressure.
  • the information shown on the display 30 may include at least some of the following components (depending on the active mode) as set forth in Table 1:
  • Mode Graphics and/or name to indicate the currently active mode (Twitch Indicator Test, Free-Run EMG, Basic Screw Test, Dynamic Screw Test, Difference Screw Test, Detection, Nerve Retractor).
  • Graphics and/or name may also be displayed to indicate the instrument in use, such as the dilator, K-wire, retractor blades, screw test instruments, and associated size information, if applicable, of the cannula, with the numeric size. If no instrument is in use, then no indicator is displayed.
  • Stimulation A graphical stimulation indicator depicting the present stimulation Bar status (i.e. on or off and stimulation current level) Sequence Shows the last seven stimulation results and provides for annotation of Bar results.
  • EMG EMG waveforms may be optionally displayed on screen along with the waveforms stimulation results.
  • Pressure Data regarding pressure being exerted upon a retracted nerve or nerve Indicia root such as the duration of retraction, the extent of retraction, and/or the resulting pressure.
  • the various functional modes capable of being performed by system 10 may include, but is not necessarily limited to, the Twitch Test, Free-run EMG, Basic Screw Test, Difference Screw Test, Dynamic Screw Test, MaXcess® Detection, Nerve Retractor, MEP Auto, MEP manual, and SSEP modes, all of which are described only briefly hereafter.
  • the Twitch Test mode is designed to assess the neuromuscular pathway via the so-called “train-of-four test” test to ensure the neuromuscular pathway is free from muscle relaxants prior to performing neurophysiology-based testing, such as bone integrity (e.g. pedicle) testing, nerve detection, and nerve retraction. This is described in greater detail within Int'l Patent App. No.
  • PCT/US2005/036089 entitled “System and Methods for Assessing the Neuromuscular Pathway Prior to Nerve Testing,” filed Oct. 7, 2005, the entire contents of which is hereby incorporated by reference as if set forth fully herein.
  • the Basic Screw Test, Difference Screw Test, and Dynamic Screw Test modes are designed to assess the integrity of bone (e.g. pedicle) during all aspects of pilot hole formation (e.g., via an awl), pilot hole preparation (e.g. via a tap), and screw introduction (during and after). These modes are described in greater detail in Int'l Patent App. No. PCT/US02/35047 entitled “System and Methods for Performing Percutaneous Pedicle Integrity Assessments,” filed on Oct.
  • the MaXcess® Detection mode is designed to detect the presence of nerves during the use of the various surgical access instruments of the neuromonitoring system 10 , including the k-wire 62 , dilator 64 , cannula 66 , retractor assembly 70 . This mode is described in greater detail within Int'l Patent App. No PCT/US02/22247, entitled “System and Methods for Determining Nerve Proximity, Direction, and Pathology During Surgery,” filed on Jul.
  • the MEP Auto and MEP Manual modes are designed to test the motor pathway to detect potential damage to the spinal cord by stimulating the motor cortex in the brain and recording the resulting EMG response of various muscles in the upper and lower extremities.
  • the SSEP function is designed to test the sensory pathway to detect potential damage to the spinal cord by stimulating peripheral nerves inferior to the target spinal level and recording the action potential from sensors superior to the spinal level.
  • the MEP Auto, MEP manual, and SSEP modes are described in greater detail within Int'l Patent App. No. PCT/US2006/003966, entitled “System and Methods for Performing Neurophysiologic Assessments During Spine Surgery,” filed on Feb.
  • the Nerve Retractor mode is designed to assess the health or pathology of a nerve before, during, and after retraction of the nerve during a surgical procedure. This mode is described in greater detail within Int'l Patent App. No. PCT/US02/30617, entitled “System and Methods for Performing Surgical Procedures and Assessments,” filed on Sep. 25, 2002, the entire contents of which is hereby incorporated by reference as if set forth fully herein.
  • Nerve pathology monitoring as it may be performed by the system 10 during Nerve Retractor mode is described hereafter in more detail.
  • the system 10 preferably accomplishes neural pathology monitoring via the Nerve Retractor mode, specifically by determining a baseline stimulation threshold (again, stimulation threshold is the value I thresh ) with direct contact between the nerve retractor 29 and the nerve, prior to retraction. Subsequent stimulation thresholds are determined during retraction and they are compared to the baseline threshold. Significant changes in the stimulation threshold may indicate potential trauma to the nerve caused by the retraction and are displayed to the user on the display 30 . An increase in I thresh over time is an indication that the nerve function is deteriorating.
  • I thresh may preferably be determined for each channel according to the multi-channel hunting algorithm described above.
  • the nerve root retractor assembly 28 shown in a preferred embodiment in FIGS. 8-10 , comprises the stimulation handpiece 36 employed with a selectively removable nerve root retractor 29 .
  • the nerve root retractor 29 has a generally angled orientation relative to the longitudinal axis of the stimulation handpiece 36 .
  • the distal end 44 is generally curved and includes an arcuate nerve engagement surface 46 equipped with, by way of example only, at least one stimulation electrode 48 .
  • the nerve root retractor 29 is preferably removable from the stimulation handpiece 36 .
  • the stimulation handpiece 36 includes a detachable cap member 50 .
  • Threads 52 are provided on the proximal end of the nerve root retractor 29 to allow a threaded coupling engagement between the stimulation handpiece 36 and the nerve root retractor 29 .
  • electrical contacts 54 on the nerve root retractor 29 become electrically coupled to the stimulation handpiece 36 such that, upon activation of one or more of the buttons 38 a stimulation current signal will be transmitted from the control unit 12 and/or patient module 14 and delivered to the stimulation electrode(s) 48 on the nerve root retractor 29 for the purpose of performing neural pathology monitoring according to the present invention.
  • the nerve root retractor 29 is preferably disposable and, as described above, the stimulation handpiece 36 is preferably reusable and sterilizable.
  • nerve retractor 29 is shown primarily in use with the stimulation handpiece 36 to form nerve retractor assembly 28 , nerve retractor 29 may be used with any suitable handle and/or may include a fixed handle. When nerve retractor 29 is used without stimulation handpiece 36 it may be coupled to the system 10 via one of the electric coupling devices 40 , 42 , a male/female type electrical coupler, or any other form of electric coupling.
  • the nerve root retractor 29 is introduced into or near a surgical target site in order to hook and retract a given nerve out of the way.
  • the nerve root may be stimulated (monopolar or bipolar) before, during, and/or after retraction in order to assess the degree to which such retraction impairs or otherwise degrades nerve function over time.
  • the user may operate one or more buttons 38 of the stimulation handpiece 36 to selectively transmit a stimulation current signal, according to the algorithm described above, from the patient module 14 to the electrode(s) 48 on the engagement surface 46 of the nerve root retractor 29 .
  • the system 10 can assess whether (and the degree to which) such retraction impairs or adversely affects nerve function over time. With this information, a user may wish to periodically release the nerve root from retraction to allow nerve function to recover, thereby preventing or minimizing the risk of long-term or irreversible nerve impairment. Similarly, an unhealthy nerve may be monitored in the same manner to determine if nerve function improves due to a particular procedure, such as spinal nerve decompression surgery.
  • the nerve retraction monitoring feature of the present invention is best viewed with regard to FIG. 11 .
  • the screen display for the Nerve Retractor mode may include any of a variety of indicia capable of communicating parameters associated with the nerve retraction monitoring feature of the present invention to a surgeon, including but not limited to, channel windows containing one or more of the channel number, myotome name, spinal level, baseline I thresh , previous I thresh , current I thresh , and the associated waveform, and various selection tabs for one or more of starting baseline stimulation, starting retraction stimulation, stopping stimulation, activating free-run EMG monitoring and adjusting the sensitivity of the free-run EMG, noting the retraction site, mode selection, annotating results, and remote messaging.
  • the nerve pathology assessments (Nerve Retractor mode) conducted by the system 10 may be further augmented via the use of any number of pressure sensing technologies working in addition to the stimulation based nerve monitoring described above and throughout this disclosure.
  • the pressure sensing features contemplated herein offer added safety and qualitative assessment features by providing the ability to monitor how much pressure is being applied to a particular nerve during nerve root retraction. This pressure may be a function of, among other factors, the degree of retraction (that is, distance the nerve is moved during retraction) and the duration of retraction. In any case, the pressure resulting on a nerve during retraction—if too high in magnitude and/or too long in duration—may result in neurologic deficit of varying degrees.
  • a user may selectively reduce the degree of retraction (such as by moving the retractor assembly 28 and nerve closer to the “natural” position of the nerve) and/or periodically releasing the nerve to avoid and/or minimize any resulting neurologic deficit due to retraction.
  • the pressure sensing technologies may include any number of commercially available and/or publicly known pressure sensing technologies, and/or those later developed.
  • the commercially available and/or publicly known pressure sensing technologies include, but are not necessarily limited to, the piezoelectric-based pressure sensing technique shown and described in U.S. Pat. No. 5,769,781 to James Chumbles, the capacitive-based pressure mapping system shown and described in U.S. Pat. No. 5,010,772 to Bourland et. al., the strain gauge-based pressure sensing technology shown and described in U.S. Pat. No. 4,784,150 to Voorhies et. al., the pressure sensitive ink-based technique shown and described in U.S. Pat. No. 5,989,700 to Krivopal, and that shown and described in U.S. Pat. No. 6,272,936 to Oreper et. al.
  • Augmenting the nerve pathology monitoring with pressure sensing capabilities may be accomplished in any number of suitable manners, including but not limited to equipping the nerve retractor assembly 28 (and more specifically, one or more of the nerve root retractor 29 , the stimulation handpiece 36 , the distal end 44 , and the nerve engagement surface 46 ) with one or more pressure sensing technologies.
  • this may be done by equipping the nerve engagement surface 46 with a pressure sensor 56 .
  • the pressure sensor 56 illustrated in FIG. 12 is a capacitive foam grid (comprising any number of suitable grid units) adhered to nerve engagement surface 46 of nerve retractor 29 .
  • pressure sensor 56 is shown herein having a small number of relatively large grid units, this is done for illustrative purposes. It will be readily understood by those skilled in the art that that any number of grid units and unit sizes may be utilized, and sensor 56 preferably comprises a large number of relatively small grid units to increase precision.
  • a data cable (not shown) may be run along the nerve retractor 29 , and is preferably integrated within the interior of nerve retractor 29 , and from there may be connected to the processing unit via cable 58 .
  • wireless communication may be used to link the pressure sensor and processing unit.
  • the processor may be control unit 12 or an additional dedicated processor may be employed for pressure sensing features.
  • pressure applied to the capacitive foam grid induces voltage responses corresponding to the affected grid units.
  • the voltage responses are relayed to the processor which translates the response into one or more of numerical and/or graphical (e.g. color) indicia relating to pressure, which may be displayed to the surgeon.
  • a separate system or device may be employed for assessing or monitoring the pressure being exerted upon a nerve or nerve root before, during and/or after nerve retraction.
  • a separate system may supplant (that is, take the place of) and/or augment (that is, serve in along with) the nerve root retractor 29 equipped with pressure sensing capabilities described above.
  • the pressure sensing features of the system 10 are controlled via a separate processing unit 60 while the EMG based nerve monitoring features are controlled via control unit 12 (as described throughout the description).
  • Processing unit 60 is preferably a personal workstation or laptop computer (by way of example only) running pressure sensing software designed to interface with the pressure sensor 56 and display pressure data to the user on the processor screen 62 .
  • One such software program is the X3 Series software distributed by XSENSORTM Technology Corporation, Calgary Canada.
  • processing unit 60 is preferably arranged near the control unit 12 such that the surgeon may view nerve pathology data from the display 30 and pressure data from screen 62 at the same time.
  • pressure applied to the retracted nerve may be a function of, among other factors, the degree of retraction (that is, distance the nerve is moved during retraction) and the duration of retraction, either of which may result in neurologic deficit of varying degrees.
  • FIG. 14 illustrates by way of example, a multi-function screen view of the pressure sensing software.
  • the multi-function screen may include (by way of example only) a 2-dimensional (2-D) grid map 64 , a 3-dimensional (3-D) grid map 66 , and a pressure distribution chart 68 , and a pressure vs.
  • the tool bar 74 and legend 72 may be found on all screen views of the pressure mapping software.
  • the tool bar 74 allows the user to select between different view screens, among other functions (such as for example, selecting the desired sensor range and precision).
  • the legend 74 indicates the numerical pressure value associated with a specific color (e.g. in one example red indicates the highest pressure of the selected range, 15.0 PSI in FIG. 14 ).
  • FIGS. 15-18 illustrate exemplary embodiments of the full screen displays.
  • FIG. 15 is a full screen display of the 2-D grid map 64 , wherein various colors are used (according to the legend 72 ) to indicate the amount of pressure measured for each grid unit on the sensor 56 .
  • a reference marker 76 is included which corresponds to a specific corner of the pressure sensor 56 , to help orient the viewer.
  • FIG. 16 illustrates the full screen display of the 3-D grid map, wherein various colors (according to the legend 72 ) are again used to indicate the amount of pressure measured on the grid units of sensor 56 .
  • FIG. 15 is a full screen display of the 2-D grid map 64 , wherein various colors are used (according to the legend 72 ) to indicate the amount of pressure measured for each grid unit on the sensor 56 .
  • a reference marker 76 is included which corresponds to a specific corner of the pressure sensor 56 , to help orient the viewer.
  • FIG. 16 illustrates the full screen display of the 3-D grid map, wherein various colors
  • FIG. 17 illustrates the full screen display of the pressure distribution graph 68 , wherein the vertical axis indicates the percentage of grid units at the given moment which are under a measured pressure falling within the pressure intervals on the horizontal axis.
  • FIG. 18 shows the full screen display of a PvT graph, wherein the maximum pressure measured on sensor 56 is charted against the retraction time.
  • the surgeon may keep be kept aware to the extent which pressure is applied to a nerve throughout retraction, and also the length of time which a nerve is retracted.
  • the 2-D and 3-D maps 64 , 66 also allow the surgeon to quickly assess not only the extent and duration of the pressure, but also the position, orientation, and center mass of the nerve retractor 29 on the nerve.
  • the processor 60 may preferably be viewed in real time, however, the processor 60 may also save the data for the entire procedure and the surgeon may go back and view any data from the same procedure at any time.
  • the pressure sensing features of the system 10 are controlled via the control unit 12 and the pressure features may be fully integrated with the Nerve Retractor mode described above.
  • both the pressure sensor 56 and the stimulation electrode 48 are communicatively linked to the patient module 14 and pressure data is preferably viewed from within the Nerve Retractor screen display (discussed above with reference to FIG. 11 ).
  • An embodiment of the Nerve Retractor screen display when system 10 is augmented with pressure sensing capabilities according to this embodiment is illustrated by way of example only in FIG. 20 .
  • the screen display includes, among its other features, a pressure selection tab 78 for initiating pressure monitoring (preferably at the same time nerve retraction) begins, a maximum pressure readout 80 , and a timer readout 82 . Selecting the pressure selection tab 78 using the GUI activates the pressure sensor 56 and starts the timer. The running time is displayed to the user in the timer readout 82 . The maximum pressure measured on the sensor 56 is displayed with constant real time updating.
  • any of a number of various features such as the 2-D and 3-D grid maps, pressure distribution, and pressure vs. time graph may also be generated and displayed in this embodiment.
  • Pressure data measured by the system 10 is recorded and saved such that it may be accessed again if necessary. Pressure data may also be included in procedure reports generated by the system 10 such that an accurate record is easily obtained.
  • monitoring retraction pressure may be useful for any number of different body tissues which must be retracted out of the way during surgery.
  • it may be extremely beneficial to monitor retraction pressure on the larynx and/or esophagus which must be retracted during anterior cervical procedure.
  • the data may be transmitted (along with the nerve pathology and other neurophysiologic assessment data) to one or more remote locations and viewable by authorized persons. This may be accomplished by any number of data transmission methods.
  • the data may be transmitted to a remote user via remote monitoring software such as that described in detail in the commonly owned and co-pending U.S. patent application Ser. No. 11/418,589, entitled “System and Methods for Performing and Monitoring Neurophysiologic Assessments,” filed on May 5, 2006, the entire contents of which are incorporated by reference herein as if set forth in its entirety.
  • the present invention may be implemented using any combination of computer programming software, firmware or hardware.
  • the computer programming code (whether software or firmware) according to the invention will typically be stored in one or more machine readable storage mediums such as fixed (hard) drives, diskettes, optical disks, magnetic tape, semiconductor memories such as ROMs, PROMs, etc., thereby making an article of manufacture in accordance with the invention.
  • the article of manufacture containing the computer programming code is used by either executing the code directly from the storage device, by copying the code from the storage device into another storage device such as a hard disk, RAM, etc. or by transmitting the code on a network for remote execution.
  • a hard disk such as a hard disk, RAM, etc.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Physiology (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)

Abstract

Systems and methods for performing neurophysiologic assessments of neural tissue including nerve pathology monitoring which may be augmented by adding the ability to assess or monitor the pressure being exerted upon a nerve or nerve root before, during and/or after retraction.

Description

    CROSS REFERENCE TO RELATED APPLICATIONS
  • This application is a continuation of U.S. application Ser. No. 11/490,717 filed Jul. 20, 2006, now U.S. Pat. No. 8,740,783, which claims the benefit of priority from commonly owned and co-pending U.S. Provisional Application No. 60/701,305 entitled “System and Methods for Determining Nerve Proximity, Nerve Direction, and Nerve Pathology During Surgery” filed Jul. 20, 2005, the entire contents of which are expressly incorporated by reference into this disclosure as if set forth herein in its entirety.
  • BACKGROUND OF THE INVENTION
  • I. Field of the Invention
  • The present invention relates to a system and methods generally aimed at surgery. More particularly, the present invention is directed at a system and related methods for performing neurophysiologic assessments with additional pressure monitoring.
  • II. Description of Related Art
  • It has been estimated that somewhere between 50 and 70 million people suffer from chronic back pain in the United States. In most cases, conservative therapies, including, for example, bed rest and physical therapy will succeed in alleviating or at least significantly reducing the back pain. Still, a significant number of patients are unaided by conservative therapies alone and undergo spinal surgery before finding relief. The rate at which caregivers and patients opt for surgery also continues to grow as medical technology advances and surgical options increase. In all, approximately 750,000 spine surgeries are performed per year in the United States alone.
  • When necessary, spine surgery may provide great benefit to the patient, often allowing patients to resume activities long since abandoned because of the debilitating pain. Spine surgery, however, is not without risk. Operating on or near the spine generally means operating in close proximity to delicate neural tissue, such as the spinal cord and nerve roots. Often, in order to reach the surgical target site the delicate nerve tissue must be retracted out of the surgical corridor. A typical nerve retractor serves to pull or otherwise maintain the nerve outside the area of surgery, thereby protecting the nerve from inadvertent damage or contact by the “active” instrumentation used to perform the actual surgery. While generally advantageous in protecting the nerve, it has been observed that such retraction can cause nerve function to become impaired or otherwise pathologic over time due to the retraction. In certain surgical applications, such as spinal surgery, it is not possible to determine if such retraction is hurting or damaging the retracted nerve until after the surgery (generally referred to as a change in “nerve health” or “nerve status”).
  • The present invention is directed at eliminating, or at least reducing the effects of, the above-described problems.
  • SUMMARY OF THE INVENTION
  • The present invention includes a system and methods capable of performing a variety of neurophysiologic assessments, and particularly nerve pathology monitoring (via Nerve Retractor mode), by combining neurophysiology monitoring with any of a variety of instruments used in or in preparation for surgery (referred to herein as “surgical accessories”). Other assessments performed by the system 10 may include one or more of, but not necessarily limited to, neuromuscular pathway status (Twitch Test), pedicle integrity testing (Screw Test), nerve proximity testing during surgical access (Detection), nerve pathology monitoring (Nerve Retractor), and detection of spontaneous muscle activity (Free Run EMG-which may be conducted alone or in conjunction with any other assessment). The nerve pathology monitoring of the present invention may be augmented by equipping a nerve root retractor with one or more pressure sensing technologies and/or providing an additional system or device for assessing or monitoring the pressure being exerted upon a nerve or nerve root before, during and/or after nerve retraction.
  • The fundamental method steps for performing the nerve pathology assessments (as well as many of the other assessments which may be performed) according to the present invention include: (a) stimulating one or more nerves with the surgical accessory (e.g. nerve retractor among others); (b) measuring the response of nerves innervated by the stimulation of step (a); (c) determining a relationship between the surgical accessory and the nerve based upon the response measured in step (b); and (d) communicating this relationship to the surgeon in an easy-to-interpret fashion.
  • The step of stimulating one or more nerves may be accomplished by applying any of a variety of suitable stimulation signals to an electrode(s) on the surgical accessory, including voltage and/or current pulses of varying magnitude and/or frequency. The stimulating step may be performed at different times depending upon the particular surgical accessory in question. For example, with regard to neural pathology monitoring, stimulation may be performed before, during and/or after retraction of the nerve root, regardless of whether additional pressure sensing features for monitoring the pressure being exerted upon a retracted nerve or nerve root are employed.
  • The step of measuring the response of nerves innervated by the stimulation step may be performed in any number of suitable fashions, including but not limited to the use of evoked muscle action potential (EMAP) monitoring techniques (that is, measuring the EMG responses of muscle groups associated with a particular nerve). According to one aspect of the present invention, the measuring step is preferably accomplished via monitoring or measuring the EMG responses of the muscles innervated by the stimulated nerve(s).
  • The step of determining a relationship between the surgical accessory and the nerve based upon the measurement step may be performed in any number of suitable fashions depending upon the manner of measuring the response, and may define the relationship in any of a variety of fashions (based on any number of suitable parameters and/or characteristics). By way of example, for neural pathology assessments according to the present invention, the relationship may be, by way of example only, whether the neurophysiologic response of the nerve has changed over time. Such changes may be quickly determined using a hunting algorithm to determine a stimulation threshold current level at various times during the procedure. According to one embodiment, these parameters may be augmented with information regarding the pressure being exerted upon a retracted nerve or nerve root.
  • The step of communicating this relationship to the surgeon in an easy-to-interpret fashion may be accomplished in any number of suitable fashions, including but not limited to the use of visual indicia (such as alpha-numeric characters, light-emitting elements, and/or graphics) and audio communications (such as a speaker element). By way of example, for nerve pathology monitoring, the determined threshold value may be visually displayed as a simple numerical value on the display. In addition, color coded graphics may be displayed to indicate the relative safety level indicated by the threshold value. When pressure sensing capabilities are added to the nerve root retractor according to one aspect of the present invention, the step of communicating the relationship to the user may also include information about the pressure being exerted upon a retracted nerve or nerve root, such as the retraction duration, the extent of retraction, and/or the resulting pressure.
  • The nerve pathology monitoring function of the present invention may be augmented with additional pressure sensing capabilities. This may be accomplished by positioning one or more pressure sensors on the nerve retractor and communicatively linking the pressure sensor to pressure mapping software on the control unit or other processor.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • Many advantages of the present invention will be apparent to those skilled in the art with a reading of this specification in conjunction with the attached drawings, wherein like reference numerals are applied to like elements and wherein:
  • FIG. 1 is a flow chart illustrating the fundamental steps of the neurophysiology-based surgical system according to the present invention;
  • FIG. 2 is a perspective view of an exemplary system 10 capable of performing neurophysiologic assessments such as for example, detecting pedicle breaches, nerve proximity (detection), nerve pathology, neuromuscular pathway status, and spinal cord health.
  • FIG. 3 is a block diagram of the system 10 shown in FIG. 2;
  • FIG. 4 is a graph illustrating an exemplary single pulse stimulation signal according to one embodiment of the present invention;
  • FIG. 5 is a is a graph illustrating an exemplary multipulse stimulation signal according to one embodiment of the present invention;
  • FIG. 6 is a graph illustrating an exemplary EMG response to the stimulus of FIG. 3 or 4;
  • FIG. 7 is a graph illustrating a plot of peak-to-peak voltage (Vpp) for each given stimulation current level (IStim) forming a stimulation current pulse train according to the present invention (otherwise known as a “recruitment curve”);
  • FIGS. 8-9 are perspective and side views, respectively, of an exemplary nerve root retractor assembly according to one embodiment of the present invention;
  • FIG. 10 is a perspective view of an exemplary nerve root retractor forming part of the assembly of FIGS. 8 and 9, according to one embodiment of the present invention;
  • FIG. 11 is an exemplary screen display illustrating one embodiment of the Nerve Retractor mode for performing neural pathology monitoring according to one embodiment of the present invention;
  • FIG. 12 is a perspective view of an exemplary nerve root retractor including a pressure sensor according to one embodiment of the present invention;
  • FIG. 13 is a perspective view of the system of FIG. 2 adapted to perform additional pressure sensing functions according to one embodiment of the present invention;
  • FIG. 14 is an exemplary multi-function screen display of the pressure sensing features of the system 10 according to one embodiment of the present invention;
  • FIG. 15 is an exemplary full screen display of the 2-dimensional pressure mapping feature according to one embodiment of the present invention;
  • FIG. 16 is an exemplary full screen display of the 3-dimensional pressure mapping feature according to one embodiment of the present invention;
  • FIG. 17 is an exemplary full screen display of the pressure distribution chart feature according to one embodiment of the present invention;
  • FIG. 18 is an exemplary full screen display of the pressure vs. time chart feature according to one embodiment of the present invention;
  • FIG. 19 is a perspective view of the system of FIG. 2 adapted to perform additional pressure sensing functions according to a different embodiment of the present invention; and
  • FIG. 20 is an exemplary screen display illustrating one embodiment of the Nerve Retractor mode for performing neural pathology monitoring augmented by pressure monitoring according to one embodiment of the present invention.
  • DESCRIPTION OF THE SPECIFIC EMBODIMENTS
  • Illustrative embodiments of the invention are described below. In the interest of clarity, not all features of an actual implementation are described in this specification. It will of course be appreciated that in the development of any such actual embodiment, numerous implementation-specific decisions must be made to achieve the developers' specific goals, such as compliance with system-related and business-related constraints, which will vary from one implementation to another. Moreover, it will be appreciated that such a development effort might be complex and time-consuming, but would nevertheless be a routine undertaking for those of ordinary skill in the art having the benefit of this disclosure. The systems disclosed herein boast a variety of inventive features and components that warrant patent protection, both individually and in combination.
  • The present invention is capable of performing a variety of neurophysiologic assessments, and particularly nerve pathology monitoring (via Nerve Retractor mode), by combining neurophysiology monitoring with any of a variety of instruments used in or in preparation for surgery (referred to herein as “surgical accessories”). Other assessments performed by the system 10 may include one or more of, but not necessarily limited to, neuromuscular pathway status (Twitch Test), pedicle integrity testing (Screw Test), nerve proximity testing during surgical access (Detection), and detection of spontaneous muscle activity (Free Run EMG—which may be conducted alone or in conjunction with any other mode). As will be described in greater detail below, the nerve pathology monitoring of the present invention may be augmented by equipping a nerve root retractor 29 with one or more pressure sensing technologies and/or providing an additional system or device for assessing or monitoring the pressure being exerted upon a nerve or nerve root before, during and/or after nerve retraction. It is expressly noted that, although described herein largely in terms of use in spinal surgery, the neuromonitoring system 10 and related methods of the present invention are suitable for use in any number of additional surgical procedures where neurological impairment due to nerve retraction is a concern.
  • FIG. 1 illustrates the fundamental method steps for performing the nerve pathology assessments (as well as many of the other assessments which may be performed) according to the present invention, namely: (a) stimulating one or more nerves with the surgical accessory (e.g. nerve retactor); (b) measuring the response of nerves innervated by the stimulation of step (a); (c) determining a relationship between the surgical accessory and the nerve based upon the response measured in step (b); and (d) communicating this relationship to the surgeon in an easy-to-interpret fashion.
  • FIGS. 2-3 illustrate, by way of example only, a surgical system 10 provided in accordance with a broad aspect of the present invention. The surgical system 10 includes a control unit 12, a patient module 14, an EMG harness 16 including 8 pairs of EMG electrodes 18 and a return electrode 22 coupled to the patient module 14, and a host of surgical accessories 24 capable of being coupled to the patient module 14 via one or more accessory cables 26. In the embodiment shown, the surgical accessories 24 include (by way of example only) a screw test assembly 27 and a nerve root retractor assembly 28. Other surgical accessories not shown here may include, but are not necessarily limited to, a K-wire, a sequential dilation access system (e.g. dilating and working cannulae), taps, pedicle access probes, tissue retractor assemblies, and surface electrodes etc. . . . Additional components, such as for example an MEP stimulator (not shown) may also be connected to the system 10.
  • The control unit 12 includes a touch screen display 30 and a base 32, which collectively contain the essential processing capabilities for controlling the surgical system 10. The patient module 14 is connected to the control unit 12 via a data cable 34 (or optionally via wireless communication), which establishes the electrical connections and communications (digital and/or analog) between the control unit 12 and patient module 14. The main functions of the control unit 12 include receiving user commands via the touch screen display 30, activating stimulation in the selected mode (e.g. Nerve Retractor), processing signal data according to defined algorithms (described below), displaying received parameters and processed data, and monitoring system status and reporting fault conditions. The touch screen display 30 is preferably equipped with a graphical user interface (GUI) capable of communicating information to the user and receiving instructions from the user. The display 30 and/or base 32 may contain patient module interface circuitry that commands the stimulation sources, receives digitized signals and other information from the patient module 14, processes the EMG responses to extract characteristic information for each muscle group, and displays the processed data to the operator via the display 30.
  • The step (a) of stimulating one or more target tissues with the surgical accessory 24 is accomplished be coupling one or more surgical accessories 24 equipped with an electrode region(s) to a stimulation source (e.g. the patient module) communicatively linked to the control unit 12. Preferably, multiple coupling options are included with the system 10 to accommodate the variety of surgical accessories and functions performed by the system 10. By way of example only, a stimulation handpiece 36 (FIG. 1) may connect to the patient module 14 via an accessory cable 26 at one end, and couple a surgical accessory 24 (e.g. nerve retractor 29—thereby forming nerve retractor assembly 28; or a pedicle probe member—thereby forming screw test assembly 27) at the other end. The stimulation handpiece 36 may include one or more buttons 38 for selectively initiating stimulation according to the selected function. In a preferred embodiment the stimulation handpiece 36 is reusable and sterilizable. By way of further example only, an electric coupling device such as, by way of example only, stimulation clip 40 and/or stimulation clip 42 (FIG. 1) may be provided to couple surgical accessories 24 (such as for example, a tap member, access probe, tissue retractor assembly, and/or various cannulae) to the system 10 such that stimulation signals may be transmitted through the tool during use. The electric coupling device may be used alone or using in conjunction with stimulation handpiece 36, as is shown. Various other connectors may also be employed to couple the surgical accessory to the stimulation source, such as for example, a male/female type socket connection and other commonly know electrical connectors.
  • The step (b) of measuring the response of nerves innervated by the stimulation of step (a) may be performed in any number of suitable fashions, including but not limited to the use of evoked muscle action potential (EMAP) monitoring techniques (that is, measuring the EMG responses of muscle groups associated with a particular nerve). In a preferred embodiment, EMG response monitoring is accomplished via 8 pairs EMG electrodes 18 (placed on the skin over the muscle groups to be monitored), a common electrode 20 providing a ground reference to pre-amplifiers in the patient module 14, and an anode electrode 22 providing a return path for the stimulation current. A preferred EMG electrode for use with the system 10 is a dual surface electrode which is shown and described in detail in the commonly owned and co-pending U.S. patent application Ser. No. 11,048,404, entitled “Improved Electrode System and Related Methods,” filed on Jan. 31, 2005, which is expressly incorporated by reference into this disclosure as if set forth in its entirety herein. It should be appreciated however, that any of a variety of known electrodes can be employed, including but not limited to surface pad electrodes and needle electrodes. It should also be appreciated that EMG electrode placement depends on a multitude of factors, including for example, the spinal cord level and particular nerves at risk and user preference, among others. In one embodiment (set forth by way of example only), the preferred EMG configuration is described for Lumbar surgery in Table 1, Thoracolumbar surgery in Table 2, and Cervical surgery in Table 3 below:
  • TABLE 1
    Lumbar
    Spinal
    Color Channel Myotome Nerve Level
    Red Right
    1 Right Vastus Medialis Femoral L2, L3, L4
    Orange Right
    2 Right Tibialis Anterior Common L4, L5
    Peroneal
    Yellow Right
    3 Right Biceps Femoris Sciatic L5, S1, S2
    Green Right
    4 Right Medial Gastroc. Post Tibial S1, S2
    Blue Left
    1 Left Vastus Medialis Femoral L2, L3, L4
    Violet Left
    2 Left Tibialis Anterior Common L4, L5
    Peroneal
    Gray Left
    3 Left Biceps Femoris Sciatic L5, S1, S2
    White Left
    4 Left Medial Gastroc. Post Tibial S1, S2
  • TABLE 2
    Thoracolumbar
    Spinal
    Color Channel Myotome Nerve Level
    Red Right
    1 Right Abductor Median C6, C7, C8, T1
    Pollicis Brevis
    Orange Right
    2 Right Vastus Medialis Femoral L2, L3, L4
    Yellow Right
    3 Right Tibialis Anterior Common L4, L5
    Peroneal
    Green Right
    4 Right Abductor Hallucis Tibial L4, L5, S1
    Blue Left
    1 Left Abductor Median C6, C7, C8, T1
    Pollicis Brevis
    Violet Left
    2 Left Vastus Medialis Femoral L2, L3, L4
    Gray Left
    3 Left Tibialis Anterior Common L4, L5
    Peroneal
    White Left
    4 Left Abductor Hallucis Tibial L4, L5, S1
  • TABLE 3
    Cervical
    Spinal
    Color Channel Myotome Nerve Level
    Red Right
    1 Right Deltoid Axilliary C5, C6
    Orange Right
    2 Right Flexor Median C6, C7, C8
    Carpi Radialis
    Yellow Right
    3 Right Abductor Median C6, C7, C8, T1
    Pollicis Brevis
    Green Right
    4 Right Abductor Hallucis Tibial L4, L5, S1
    Blue Left
    1 Left Deltoid Axillary C5, C6
    Violet Left
    2 Left Flexor Median C6, C7, C8
    Carpi Radialis
    Gray Left
    3 Left Abductor Median C6, C7, C8, T1
    Pollicis Brevis
    White Left
    4 Left Abductor Hallucis Tibial L4, L5, S1
  • The step (c) of determining a relationship between the surgical accessory and the nerve based upon the response measured in step (b) may be performed in any number of suitable fashions depending upon the manner of measuring the response, and may define the relationship in any of a variety of fashions based on any number of suitable parameters and/or characteristics). By way of example only, the step of determining a relationship, within the context of a nerve pathology assessment, may involve identifying what stimulation current level is required to evoke a significant muscle response (i.e. the relationship between the surgical accessory (and more specifically the stimulation signal emitted from the surgical accessory) and the nerve may be defined as the stimulation threshold current level, described below).
  • A basic premise underlying the methods employed by the system 10 for much of the neurophysiologic monitoring conducted is that neurons and nerves have characteristic threshold current levels (IThresh) at which they will depolarize, resulting in detectable muscle activity. Below this threshold current, stimulation signals, such as the single pulse signal shown by way of example only in FIG. 4 and the multi-pulse signal shown by way of example only in FIG. 5, will not evoke a significant EMG response. Each EMG response can be characterized by a peak-to-peak voltage of Vpp=Vmax−Vmin, shown in FIG. 6. Once the stimulation threshold (IThresh) is reached, the evoked response is reproducible and increases with increasing stimulation until saturation is reached as shown in FIG. 7. This is known as a “recruitment curve.” In one embodiment, a significant EMG response is defined as having a Vpp of approximately 100 uV. The lowest stimulation signal current, Istim that evokes this threshold voltage (VThresh) is called IThresh. Finding Ithresh is useful in making neurophysiologic assessments because it provides a relative indication as to the degree of communication between a stimulation signal and nerve tissue. For example, as the degree of electrical communication between a stimulation signal and a nerve decreases, Ithresh will increase. Conversely, as the degree of communication between the stimulation signal and a nerve increases, Ithresh will decrease.
  • The system 10 capitalizes on and enhances the information derived from Ithresh by quickly, accurately, and efficiently finding Ithresh and comparing the determined value against predetermined safety indicator levels. Armed with the useful information conveyed by the system 10, the surgeon may detect early on any problem or potential problem and then act to avoid and/or mitigate the situation. By way of general example only, an excessively high Ithresh or an increase over a previous Ithresh measurement during Nerve Retractor mode may indicate a deterioration of nerve root function caused by excessive and/or prolonged retraction. On the opposite hand, a decrease in Ithresh over previous measurements may indicate During Screw Test and Detection modes, a low Ithresh value may indicate a breach in the pedicle, or the close proximity of a nerve, respectively.
  • To quickly determine Ithresh, the system 10 may employ a variety of suitable algorithms and techniques which are described in detail in the “NeuroVision Applications,” all of which are incorporated by reference below, as if they were set forth herein in their entireties. One exemplary threshold hunting algorithm is described hereafter in only brief detail. The threshold hunting algorithm utilizes a bracketing method and a bisection method to find Ithresh. The bracketing method finds a range (bracket) of stimulation currents that must contain Ithresh. To accomplish this, the algorithm directs stimulation to begin at a predetermined current level (based on the selected function). For each subsequent stimulation, the current level is doubled from the previous current level. This doubling continues until a until a stimulation current recruits, that is, results in an EMG response with a Vpp greater or equal to Vthresh (e.g. 100 uV). This first stimulation current to recruit, together with the last stimulation current to have not recruited, forms the initial bracket. If the stimulation current threshold, Ithresh, of a channel exceeds a maximum stimulation current, that threshold is considered out of range.
  • After the bracket containing the threshold current Ithresh has been determined, the initial bracket is successively reduced via the bisection method to a predetermined width. This is accomplished by applying a first bisection stimulation current that bisects (i.e. forms the midpoint of) the initial bracket. If this first bisection stimulation current recruits, the bracket is reduced to the lower half of the initial bracket. If this first bisection stimulation current does not recruit, the bracket is reduced to the upper half of the initial bracket. This process is continued for each successive bracket until Ithresh is bracketed by stimulation currents separated by the predetermined width. In one embodiment, the midpoint of this final bracket may be defined as Ithresh; however, any value falling within the final bracket may be selected as Ithresh without departing from the scope of the present invention.
  • During some functions (e.g. Screw Tests and Detection) stimulations may stop after Ithresh is determined for the channel possessing the lowest Ithresh. For other functions (e.g. Nerve Retractor), however, it may useful to determine Ithresh for every channel. To accomplish this quickly, the hunting algorithm may employ additional methods allowing it to omit certain stimulations, thereby reducing the number of stimulations and time required to obtain an Ithresh value on each channel. Ithresh is still found using the bracketing and bisection methods described above, however the algorithm will omit stimulations for which the result is predictable from data previously acquired. When a stimulation signal is omitted, the algorithm proceeds as if the stimulation had taken place. This permits the algorithm to proceed to the next required stimulation immediately, without a time delay inherently associated with each stimulation signal. To further reduce the number of stimulations required over the time frame of an entire surgical procedure, the algorithm may confirm previously obtained Ithresh values (e.g. by stimulation at current levels just below and at/or just above Ithresh and determining whether the resulting responses are consistent with the previously acquired Ithresh value), rather than initiating stimulations from the beginning each time a function is performed.
  • The final step (d) of communicating this relationship to the surgeon in an easy-to-interpret fashion may be accomplished in any number of suitable fashions, including but not limited to the use of visual indicia (such as alpha-numeric characters, light-emitting elements, and/or graphics) and audio communications (such as a speaker element). By way of example only, the determined Ithresh value may be visually displayed as a simple numerical value on display 30. In addition, color coded graphics may be displayed to indicate the relative safety level indicated by the Ithresh (e.g. “green” for a range of stimulation thresholds below (or above, depending on the selected mode) a predetermined safe value, “red” for a range of stimulation thresholds above (or below, depending on the mode) a predetermined unsafe value, and “yellow” for the range of stimulation thresholds in between the predetermined safe and unsafe values—designating caution). When pressure sensing capabilities are added to the nerve root retractor according to one aspect of the present invention, the step of communicating the relationship to the user may also include information about the pressure being exerted upon a retracted nerve or nerve root, such as the retraction duration, the extent of retraction, and/or the resulting pressure. In one embodiment, set forth by way of example only, the information shown on the display 30 may include at least some of the following components (depending on the active mode) as set forth in Table 1:
  • TABLE 1
    Screen
    Component Description
    Spine An image of the human body/skeleton showing the electrode placement
    Image on the body, with labeled channel number tabs on each side (1-4 on the
    left and right). Left and right labels will show the patient orientation.
    The channel number tabs may be highlighted or colored depending on
    the specific function being performed.
    Myotome & A label to indicate the Myotome name and corresponding Spinal
    Level Level(s) associated with the channel of interest.
    Names
    Menu A drop down navigation component for toggling between functions.
    Display Shows procedure-specific information including stimulation results.
    Area
    Color Enhances stimulation results with a color display of green, yellow, or
    Indication red corresponding to the relative safety level determined by the system.
    Mode Graphics and/or name to indicate the currently active mode (Twitch
    Indicator Test, Free-Run EMG, Basic Screw Test, Dynamic Screw Test,
    Difference Screw Test, Detection, Nerve Retractor). In an alternate
    embodiment, Graphics and/or name may also be displayed to indicate
    the instrument in use, such as the dilator, K-wire, retractor blades,
    screw test instruments, and associated size information, if applicable,
    of the cannula, with the numeric size. If no instrument is in use, then
    no indicator is displayed.
    Stimulation A graphical stimulation indicator depicting the present stimulation
    Bar status (i.e. on or off and stimulation current level)
    Sequence Shows the last seven stimulation results and provides for annotation of
    Bar results.
    EMG EMG waveforms may be optionally displayed on screen along with the
    waveforms stimulation results.
    Pressure Data regarding pressure being exerted upon a retracted nerve or nerve
    Indicia root, such as the duration of retraction, the extent of retraction, and/or
    the resulting pressure.
  • By way of example only, the various functional modes capable of being performed by system 10 may include, but is not necessarily limited to, the Twitch Test, Free-run EMG, Basic Screw Test, Difference Screw Test, Dynamic Screw Test, MaXcess® Detection, Nerve Retractor, MEP Auto, MEP manual, and SSEP modes, all of which are described only briefly hereafter. The Twitch Test mode is designed to assess the neuromuscular pathway via the so-called “train-of-four test” test to ensure the neuromuscular pathway is free from muscle relaxants prior to performing neurophysiology-based testing, such as bone integrity (e.g. pedicle) testing, nerve detection, and nerve retraction. This is described in greater detail within Int'l Patent App. No. PCT/US2005/036089, entitled “System and Methods for Assessing the Neuromuscular Pathway Prior to Nerve Testing,” filed Oct. 7, 2005, the entire contents of which is hereby incorporated by reference as if set forth fully herein. The Basic Screw Test, Difference Screw Test, and Dynamic Screw Test modes are designed to assess the integrity of bone (e.g. pedicle) during all aspects of pilot hole formation (e.g., via an awl), pilot hole preparation (e.g. via a tap), and screw introduction (during and after). These modes are described in greater detail in Int'l Patent App. No. PCT/US02/35047 entitled “System and Methods for Performing Percutaneous Pedicle Integrity Assessments,” filed on Oct. 30, 2002, and PCT/US2004/025550, entitled “System and Methods for Performing Dynamic Pedicle Integrity Assessments,” filed on Aug. 5, 2004 the entire contents of which are both hereby incorporated by reference as if set forth fully herein. The MaXcess® Detection mode is designed to detect the presence of nerves during the use of the various surgical access instruments of the neuromonitoring system 10, including the k-wire 62, dilator 64, cannula 66, retractor assembly 70. This mode is described in greater detail within Int'l Patent App. No PCT/US02/22247, entitled “System and Methods for Determining Nerve Proximity, Direction, and Pathology During Surgery,” filed on Jul. 11, 2002, the entire contents of which is hereby incorporated by reference as if set forth fully herein. The MEP Auto and MEP Manual modes are designed to test the motor pathway to detect potential damage to the spinal cord by stimulating the motor cortex in the brain and recording the resulting EMG response of various muscles in the upper and lower extremities. The SSEP function is designed to test the sensory pathway to detect potential damage to the spinal cord by stimulating peripheral nerves inferior to the target spinal level and recording the action potential from sensors superior to the spinal level. The MEP Auto, MEP manual, and SSEP modes are described in greater detail within Int'l Patent App. No. PCT/US2006/003966, entitled “System and Methods for Performing Neurophysiologic Assessments During Spine Surgery,” filed on Feb. 2, 2006, the entire contents of which is hereby incorporated by reference as if set forth fully herein. The Nerve Retractor mode is designed to assess the health or pathology of a nerve before, during, and after retraction of the nerve during a surgical procedure. This mode is described in greater detail within Int'l Patent App. No. PCT/US02/30617, entitled “System and Methods for Performing Surgical Procedures and Assessments,” filed on Sep. 25, 2002, the entire contents of which is hereby incorporated by reference as if set forth fully herein.
  • Nerve pathology monitoring as it may be performed by the system 10 during Nerve Retractor mode is described hereafter in more detail. The system 10 preferably accomplishes neural pathology monitoring via the Nerve Retractor mode, specifically by determining a baseline stimulation threshold (again, stimulation threshold is the value Ithresh) with direct contact between the nerve retractor 29 and the nerve, prior to retraction. Subsequent stimulation thresholds are determined during retraction and they are compared to the baseline threshold. Significant changes in the stimulation threshold may indicate potential trauma to the nerve caused by the retraction and are displayed to the user on the display 30. An increase in Ithresh over time is an indication that the nerve function is deteriorating. By monitoring this the surgeon may intra-operatively assess if the retracted nerve is being damaged or otherwise compromised (such as due to a prolonged surgery), such that it can be temporarily released to allow it to recover before returning to retraction to continue with the surgery. It's believed that releasing the nerve root in this fashion will prevent or reduce the adverse effects (nerve function compromise) that may otherwise result from prolonged retraction. Changes in Ithresh in the opposite direction (i.e. decreases in Ithresh over time) may indicate that the surgical procedure is improving or aiding a previously unhealthy nerve, such as during spinal decompression surgery. For accurate and timely information, Ithresh may preferably be determined for each channel according to the multi-channel hunting algorithm described above.
  • The nerve root retractor assembly 28, shown in a preferred embodiment in FIGS. 8-10, comprises the stimulation handpiece 36 employed with a selectively removable nerve root retractor 29. The nerve root retractor 29 has a generally angled orientation relative to the longitudinal axis of the stimulation handpiece 36. The distal end 44 is generally curved and includes an arcuate nerve engagement surface 46 equipped with, by way of example only, at least one stimulation electrode 48. As best shown in FIG. 10, the nerve root retractor 29 is preferably removable from the stimulation handpiece 36. To accomplish this, the stimulation handpiece 36 includes a detachable cap member 50. Threads 52 are provided on the proximal end of the nerve root retractor 29 to allow a threaded coupling engagement between the stimulation handpiece 36 and the nerve root retractor 29. During such engagement, electrical contacts 54 on the nerve root retractor 29 become electrically coupled to the stimulation handpiece 36 such that, upon activation of one or more of the buttons 38 a stimulation current signal will be transmitted from the control unit 12 and/or patient module 14 and delivered to the stimulation electrode(s) 48 on the nerve root retractor 29 for the purpose of performing neural pathology monitoring according to the present invention. The nerve root retractor 29 is preferably disposable and, as described above, the stimulation handpiece 36 is preferably reusable and sterilizable. It should be understood that while the nerve retractor 29 is shown primarily in use with the stimulation handpiece 36 to form nerve retractor assembly 28, nerve retractor 29 may be used with any suitable handle and/or may include a fixed handle. When nerve retractor 29 is used without stimulation handpiece 36 it may be coupled to the system 10 via one of the electric coupling devices 40, 42, a male/female type electrical coupler, or any other form of electric coupling.
  • In use, the nerve root retractor 29 is introduced into or near a surgical target site in order to hook and retract a given nerve out of the way. According to the present invention, the nerve root may be stimulated (monopolar or bipolar) before, during, and/or after retraction in order to assess the degree to which such retraction impairs or otherwise degrades nerve function over time. To do so, the user may operate one or more buttons 38 of the stimulation handpiece 36 to selectively transmit a stimulation current signal, according to the algorithm described above, from the patient module 14 to the electrode(s) 48 on the engagement surface 46 of the nerve root retractor 29. By monitoring the myotome(s) associated with the nerve root being retracted (via the EMG harness 16) and assessing the resulting EMG responses to preferably determine Ithresh (via the control unit 12), the system 10 can assess whether (and the degree to which) such retraction impairs or adversely affects nerve function over time. With this information, a user may wish to periodically release the nerve root from retraction to allow nerve function to recover, thereby preventing or minimizing the risk of long-term or irreversible nerve impairment. Similarly, an unhealthy nerve may be monitored in the same manner to determine if nerve function improves due to a particular procedure, such as spinal nerve decompression surgery.
  • The nerve retraction monitoring feature of the present invention is best viewed with regard to FIG. 11. The screen display for the Nerve Retractor mode may include any of a variety of indicia capable of communicating parameters associated with the nerve retraction monitoring feature of the present invention to a surgeon, including but not limited to, channel windows containing one or more of the channel number, myotome name, spinal level, baseline Ithresh, previous Ithresh, current Ithresh, and the associated waveform, and various selection tabs for one or more of starting baseline stimulation, starting retraction stimulation, stopping stimulation, activating free-run EMG monitoring and adjusting the sensitivity of the free-run EMG, noting the retraction site, mode selection, annotating results, and remote messaging.
  • As described above, the nerve pathology assessments (Nerve Retractor mode) conducted by the system 10 may be further augmented via the use of any number of pressure sensing technologies working in addition to the stimulation based nerve monitoring described above and throughout this disclosure. The pressure sensing features contemplated herein offer added safety and qualitative assessment features by providing the ability to monitor how much pressure is being applied to a particular nerve during nerve root retraction. This pressure may be a function of, among other factors, the degree of retraction (that is, distance the nerve is moved during retraction) and the duration of retraction. In any case, the pressure resulting on a nerve during retraction—if too high in magnitude and/or too long in duration—may result in neurologic deficit of varying degrees. By monitoring the pressure according to the present invention, a user may selectively reduce the degree of retraction (such as by moving the retractor assembly 28 and nerve closer to the “natural” position of the nerve) and/or periodically releasing the nerve to avoid and/or minimize any resulting neurologic deficit due to retraction.
  • The pressure sensing technologies may include any number of commercially available and/or publicly known pressure sensing technologies, and/or those later developed. The commercially available and/or publicly known pressure sensing technologies include, but are not necessarily limited to, the piezoelectric-based pressure sensing technique shown and described in U.S. Pat. No. 5,769,781 to James Chappuis, the capacitive-based pressure mapping system shown and described in U.S. Pat. No. 5,010,772 to Bourland et. al., the strain gauge-based pressure sensing technology shown and described in U.S. Pat. No. 4,784,150 to Voorhies et. al., the pressure sensitive ink-based technique shown and described in U.S. Pat. No. 5,989,700 to Krivopal, and that shown and described in U.S. Pat. No. 6,272,936 to Oreper et. al.
  • Augmenting the nerve pathology monitoring with pressure sensing capabilities may be accomplished in any number of suitable manners, including but not limited to equipping the nerve retractor assembly 28 (and more specifically, one or more of the nerve root retractor 29, the stimulation handpiece 36, the distal end 44, and the nerve engagement surface 46) with one or more pressure sensing technologies. By way of example only, with reference to FIG. 9, this may be done by equipping the nerve engagement surface 46 with a pressure sensor 56. By way of example only, the pressure sensor 56 illustrated in FIG. 12 is a capacitive foam grid (comprising any number of suitable grid units) adhered to nerve engagement surface 46 of nerve retractor 29. While pressure sensor 56 is shown herein having a small number of relatively large grid units, this is done for illustrative purposes. It will be readily understood by those skilled in the art that that any number of grid units and unit sizes may be utilized, and sensor 56 preferably comprises a large number of relatively small grid units to increase precision. To communicatively link the pressure sensor 56 to a processor unit, a data cable (not shown) may be run along the nerve retractor 29, and is preferably integrated within the interior of nerve retractor 29, and from there may be connected to the processing unit via cable 58. Alternatively, wireless communication may be used to link the pressure sensor and processing unit. As will be discussed below, the processor may be control unit 12 or an additional dedicated processor may be employed for pressure sensing features. In use, pressure applied to the capacitive foam grid induces voltage responses corresponding to the affected grid units. The voltage responses are relayed to the processor which translates the response into one or more of numerical and/or graphical (e.g. color) indicia relating to pressure, which may be displayed to the surgeon.
  • According to a further embodiment of the present invention, a separate system or device may be employed for assessing or monitoring the pressure being exerted upon a nerve or nerve root before, during and/or after nerve retraction. Such a separate system may supplant (that is, take the place of) and/or augment (that is, serve in along with) the nerve root retractor 29 equipped with pressure sensing capabilities described above.
  • With reference to FIG. 13, according to one embodiment, set forth by way of example only, the pressure sensing features of the system 10 are controlled via a separate processing unit 60 while the EMG based nerve monitoring features are controlled via control unit 12 (as described throughout the description). Processing unit 60 is preferably a personal workstation or laptop computer (by way of example only) running pressure sensing software designed to interface with the pressure sensor 56 and display pressure data to the user on the processor screen 62. One such software program, by way of example only, is the X3 Series software distributed by XSENSOR™ Technology Corporation, Calgary Canada. In use, processing unit 60 is preferably arranged near the control unit 12 such that the surgeon may view nerve pathology data from the display 30 and pressure data from screen 62 at the same time.
  • As previously mentioned, pressure applied to the retracted nerve may be a function of, among other factors, the degree of retraction (that is, distance the nerve is moved during retraction) and the duration of retraction, either of which may result in neurologic deficit of varying degrees. With reference to FIG. 14, various pressure mapping features of the present embodiment that allow the surgeon to asses both the extent and duration of pressure applied to the retracted nerve are illustrated. FIG. 14 illustrates by way of example, a multi-function screen view of the pressure sensing software. The multi-function screen may include (by way of example only) a 2-dimensional (2-D) grid map 64, a 3-dimensional (3-D) grid map 66, and a pressure distribution chart 68, and a pressure vs. time (PvT) chart 70, a legend 72, and a tool bar 74. The tool bar 74 and legend 72 may be found on all screen views of the pressure mapping software. The tool bar 74 allows the user to select between different view screens, among other functions (such as for example, selecting the desired sensor range and precision). The legend 74 indicates the numerical pressure value associated with a specific color (e.g. in one example red indicates the highest pressure of the selected range, 15.0 PSI in FIG. 14).
  • FIGS. 15-18 illustrate exemplary embodiments of the full screen displays. FIG. 15 is a full screen display of the 2-D grid map 64, wherein various colors are used (according to the legend 72) to indicate the amount of pressure measured for each grid unit on the sensor 56. A reference marker 76 is included which corresponds to a specific corner of the pressure sensor 56, to help orient the viewer. FIG. 16 illustrates the full screen display of the 3-D grid map, wherein various colors (according to the legend 72) are again used to indicate the amount of pressure measured on the grid units of sensor 56. FIG. 17 illustrates the full screen display of the pressure distribution graph 68, wherein the vertical axis indicates the percentage of grid units at the given moment which are under a measured pressure falling within the pressure intervals on the horizontal axis. FIG. 18 shows the full screen display of a PvT graph, wherein the maximum pressure measured on sensor 56 is charted against the retraction time.
  • Utilizing the various functions of the pressure mapping software, the surgeon may keep be kept aware to the extent which pressure is applied to a nerve throughout retraction, and also the length of time which a nerve is retracted. In addition, the 2-D and 3- D maps 64, 66 also allow the surgeon to quickly assess not only the extent and duration of the pressure, but also the position, orientation, and center mass of the nerve retractor 29 on the nerve. By way of example only, should either of the grid maps indicate that pressure is highest around one edge it may indicate that the nerve is not resting in the ideal position (e.g. centered and flat against the nerve engagement surface 46) and the surgeon may act to reposition the nerve relative to the nerve retractor. Pressure data collected by the processor 60 may preferably be viewed in real time, however, the processor 60 may also save the data for the entire procedure and the surgeon may go back and view any data from the same procedure at any time.
  • In another embodiment, set forth herein by way of example only and depicted in FIG. 19, the pressure sensing features of the system 10 are controlled via the control unit 12 and the pressure features may be fully integrated with the Nerve Retractor mode described above. In this embodiment, both the pressure sensor 56 and the stimulation electrode 48 are communicatively linked to the patient module 14 and pressure data is preferably viewed from within the Nerve Retractor screen display (discussed above with reference to FIG. 11). An embodiment of the Nerve Retractor screen display when system 10 is augmented with pressure sensing capabilities according to this embodiment is illustrated by way of example only in FIG. 20. In the example shown, the screen display includes, among its other features, a pressure selection tab 78 for initiating pressure monitoring (preferably at the same time nerve retraction) begins, a maximum pressure readout 80, and a timer readout 82. Selecting the pressure selection tab 78 using the GUI activates the pressure sensor 56 and starts the timer. The running time is displayed to the user in the timer readout 82. The maximum pressure measured on the sensor 56 is displayed with constant real time updating. Although not shown herein, it will be appreciated that any of a number of various features such as the 2-D and 3-D grid maps, pressure distribution, and pressure vs. time graph may also be generated and displayed in this embodiment. This may be accomplished, for example only, by providing one or more pop-up windows displaying the data and/or rearranging the screen view. Pressure data measured by the system 10 is recorded and saved such that it may be accessed again if necessary. Pressure data may also be included in procedure reports generated by the system 10 such that an accurate record is easily obtained.
  • While the pressure sensing features herein have been described above in terms of monitoring retraction pressure on nerves it will be understood that monitoring retraction pressure may be useful for any number of different body tissues which must be retracted out of the way during surgery. By way of example only, it may be extremely beneficial to monitor retraction pressure on the larynx and/or esophagus which must be retracted during anterior cervical procedure.
  • It may also be advantageous to communicate pressure related data captured by the system 10 to persons not present in the operating room. It is contemplated that the data may be transmitted (along with the nerve pathology and other neurophysiologic assessment data) to one or more remote locations and viewable by authorized persons. This may be accomplished by any number of data transmission methods. In one example, the data may be transmitted to a remote user via remote monitoring software such as that described in detail in the commonly owned and co-pending U.S. patent application Ser. No. 11/418,589, entitled “System and Methods for Performing and Monitoring Neurophysiologic Assessments,” filed on May 5, 2006, the entire contents of which are incorporated by reference herein as if set forth in its entirety.
  • While this invention has been described in terms of a best mode for achieving this invention's objectives, it will be appreciated by those skilled in the art that variations may be accomplished in view of these teachings without deviating from the spirit or scope of the present invention. For example, the present invention may be implemented using any combination of computer programming software, firmware or hardware. As a preparatory step to practicing the invention or constructing an apparatus according to the invention, the computer programming code (whether software or firmware) according to the invention will typically be stored in one or more machine readable storage mediums such as fixed (hard) drives, diskettes, optical disks, magnetic tape, semiconductor memories such as ROMs, PROMs, etc., thereby making an article of manufacture in accordance with the invention. The article of manufacture containing the computer programming code is used by either executing the code directly from the storage device, by copying the code from the storage device into another storage device such as a hard disk, RAM, etc. or by transmitting the code on a network for remote execution. As can be envisioned by one of skill in the art, many different combinations of the above may be used and accordingly the present invention is not limited by the scope of the appended claims.

Claims (9)

What is claimed is:
1. A method for assessing the pathology of a nerve, comprising the steps of:
retracting a nerve within a patient using a nerve retractor having a plurality of pressure sensors and at least one stimulation electrode situated on a nerve contacting head of the retractor, wherein said at least one stimulation electrode is configured to deliver an electrical stimulation signal to a nerve within a patient;
delivering an electrical stimulation signal to said nerve with said stimulation electrode;
detecting an neuromuscular response evoked by said stimulation signal using at least one electrical sensor in electrical communication with said at least one stimulation electrode to detect neuromuscular responses evoked by said stimulation signal;
using a control unit communicatively linked to said stimulation electrode and said electrical sensor to identify a relationship between said stimulation signal and said neuromuscular response;
calculating the pressure exerted on at least two locations along said nerve by said nerve retractor using a processing unit communicatively linked to said pressure sensors; and
displaying pressure mapping data on a display linked to said processing unit in at least two dimensions based on said calculated pressure exerted on said at least two locations along said nerve.
2. The method of claim 1, wherein said display further provides at least one of additional alpha-numeric and graphic indicia relating to said calculated pressure.
3. The method of claim 2, wherein said alpha-numeric and graphic indicia includes at least one of a maximum pressure value, time value, color, chart, and a graph.
4. The method of claim 1, wherein said control unit includes a display and said display provides at last one of alpha-numeric and graphic indicia relating to said identified relationship.
5. The method of claim 1, wherein said identified relationship is the lowest stimulation current necessary to evoke a neuromuscular response.
6. The method of claim 5, wherein said control unit is configured to perform a threshold hunting algorithm to identify the lowest stimulation current necessary to evoke a neuromuscular response.
7. The method of claim 1, wherein said control unit and said processing unit are a single unit.
8. The method of claim 1, wherein said control unit and said processing unit are distinct units.
9. The method of claim 1, wherein said pressure mapping data is 3-dimensional pressure mapping data.
US14/294,304 2005-07-20 2014-06-03 Systems and Methods for Performing Neurophysiologic Assessments with Pressure Monitoring Abandoned US20140288389A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US14/294,304 US20140288389A1 (en) 2005-07-20 2014-06-03 Systems and Methods for Performing Neurophysiologic Assessments with Pressure Monitoring

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US70130505P 2005-07-20 2005-07-20
US11/490,717 US8740783B2 (en) 2005-07-20 2006-07-20 System and methods for performing neurophysiologic assessments with pressure monitoring
US14/294,304 US20140288389A1 (en) 2005-07-20 2014-06-03 Systems and Methods for Performing Neurophysiologic Assessments with Pressure Monitoring

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US11/490,717 Continuation US8740783B2 (en) 2005-07-20 2006-07-20 System and methods for performing neurophysiologic assessments with pressure monitoring

Publications (1)

Publication Number Publication Date
US20140288389A1 true US20140288389A1 (en) 2014-09-25

Family

ID=37680020

Family Applications (3)

Application Number Title Priority Date Filing Date
US11/490,717 Active 2030-01-17 US8740783B2 (en) 2005-07-20 2006-07-20 System and methods for performing neurophysiologic assessments with pressure monitoring
US12/817,161 Abandoned US20100317989A1 (en) 2005-07-20 2010-06-16 Systems and Methods for Performing Neurophysiologic Assesments With Pressure Monitoring
US14/294,304 Abandoned US20140288389A1 (en) 2005-07-20 2014-06-03 Systems and Methods for Performing Neurophysiologic Assessments with Pressure Monitoring

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US11/490,717 Active 2030-01-17 US8740783B2 (en) 2005-07-20 2006-07-20 System and methods for performing neurophysiologic assessments with pressure monitoring
US12/817,161 Abandoned US20100317989A1 (en) 2005-07-20 2010-06-16 Systems and Methods for Performing Neurophysiologic Assesments With Pressure Monitoring

Country Status (1)

Country Link
US (3) US8740783B2 (en)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9533155B2 (en) 2014-08-15 2017-01-03 Axonics Modulation Technologies, Inc. Methods for determining neurostimulation electrode configurations based on neural localization
US9555246B2 (en) 2014-08-15 2017-01-31 Axonics Modulation Technologies, Inc. Electromyographic lead positioning and stimulation titration in a nerve stimulation system for treatment of overactive bladder
US10092762B2 (en) 2014-08-15 2018-10-09 Axonics Modulation Technologies, Inc. Integrated electromyographic clinician programmer for use with an implantable neurostimulator
US11026627B2 (en) 2013-03-15 2021-06-08 Cadwell Laboratories, Inc. Surgical instruments for determining a location of a nerve during a procedure
US11177610B2 (en) 2017-01-23 2021-11-16 Cadwell Laboratories, ino. Neuromonitoring connection system
US11253182B2 (en) 2018-05-04 2022-02-22 Cadwell Laboratories, Inc. Apparatus and method for polyphasic multi-output constant-current and constant-voltage neurophysiological stimulation
US11439829B2 (en) 2019-05-24 2022-09-13 Axonics, Inc. Clinician programmer methods and systems for maintaining target operating temperatures
US11443649B2 (en) 2018-06-29 2022-09-13 Cadwell Laboratories, Inc. Neurophysiological monitoring training simulator
US11701047B2 (en) 2017-06-16 2023-07-18 Alphatec Spine, Inc. Systems, methods, and devices for detecting the threshold of nerve-muscle response using variable frequency of stimulation
US11848090B2 (en) 2019-05-24 2023-12-19 Axonics, Inc. Trainer for a neurostimulator programmer and associated methods of use with a neurostimulation system
US11963775B2 (en) 2017-03-22 2024-04-23 Safeop Surgical, Inc. Medical systems and methods for detecting changes in electrophysiological evoked potentials
US11963784B2 (en) 2013-11-07 2024-04-23 Safeop Surgical, Inc. Systems and methods for detecting nerve function
US11986321B2 (en) 2016-09-22 2024-05-21 Safeop Surgical, Inc. System and method for detecting and removing periodic non-physiological artifact from evoked potentials
US11992339B2 (en) 2018-05-04 2024-05-28 Cadwell Laboratories, Inc. Systems and methods for dynamic neurophysiological stimulation
US12048567B2 (en) 2015-05-04 2024-07-30 Safeop Surgical, Inc. System, method, and computer algorithm for measuring, displaying, and accurately detecting changes in electrophysiological evoked potentials

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4854900B2 (en) 1999-11-24 2012-01-18 ヌバシブ, インコーポレイテッド EMG measurement method
JP4295086B2 (en) 2001-07-11 2009-07-15 ヌバシブ, インコーポレイテッド System and method for determining nerve proximity, nerve orientation, and pathology during surgery
EP1435828A4 (en) 2001-09-25 2009-11-11 Nuvasive Inc System and methods for performing surgical procedures and assessments
US7582058B1 (en) 2002-06-26 2009-09-01 Nuvasive, Inc. Surgical access system and related methods
US8137284B2 (en) 2002-10-08 2012-03-20 Nuvasive, Inc. Surgical access system and related methods
US7691057B2 (en) 2003-01-16 2010-04-06 Nuvasive, Inc. Surgical access system and related methods
US7819801B2 (en) 2003-02-27 2010-10-26 Nuvasive, Inc. Surgical access system and related methods
US7905840B2 (en) * 2003-10-17 2011-03-15 Nuvasive, Inc. Surgical access system and related methods
EP1680177B1 (en) 2003-09-25 2017-04-12 NuVasive, Inc. Surgical access system
US8313430B1 (en) 2006-01-11 2012-11-20 Nuvasive, Inc. Surgical access system and related methods
US9795367B1 (en) * 2003-10-17 2017-10-24 Nuvasive, Inc. Surgical access system and related methods
WO2007038290A2 (en) * 2005-09-22 2007-04-05 Nuvasive, Inc. Multi-channel stimulation threshold detection algorithm for use in neurophysiology monitoring
AU2008236665B2 (en) * 2007-04-03 2013-08-22 Nuvasive, Inc. Neurophysiologic monitoring system
BRPI0818608A2 (en) 2007-10-05 2015-04-22 Synthes Gmbh Sequential directional dilatation system for dilating from a nerve of a patient's anatomy, and method for forming an access opening through a psoas muscle to a patient's spine using a dilatation system
US7811138B2 (en) * 2008-02-29 2010-10-12 Pioneer Surgical Technology, Inc. Electrical connector for surgical systems
US8137285B1 (en) * 2008-08-26 2012-03-20 Rhythmlink International, Llc Monopolar stimulation probe system
WO2010044880A1 (en) * 2008-10-15 2010-04-22 Nuvasive, Inc. Neurophysiologic monitoring system and related methods
US9084551B2 (en) 2008-12-08 2015-07-21 Medtronic Xomed, Inc. Method and system for monitoring a nerve
CA2750917A1 (en) 2008-12-26 2010-07-01 Scott Spann Minimally-invasive retroperitoneal lateral approach for spinal surgery
AU2010247953A1 (en) * 2009-05-11 2012-01-12 Hyun Woo Bae Neurologic monitoring system and method
US20110230785A1 (en) * 2010-03-16 2011-09-22 ProNerve, LLC Somatosensory Evoked Potential (SSEP) Automated Alert System
US9392953B1 (en) * 2010-09-17 2016-07-19 Nuvasive, Inc. Neurophysiologic monitoring
WO2012040206A1 (en) 2010-09-20 2012-03-29 Synthes Usa, Llc Spinal access retractor
US9155503B2 (en) * 2010-10-27 2015-10-13 Cadwell Labs Apparatus, system, and method for mapping the location of a nerve
US9808232B2 (en) 2011-11-01 2017-11-07 DePuy Synthes Products, Inc. Dilation system
US9265490B2 (en) 2012-04-16 2016-02-23 DePuy Synthes Products, Inc. Detachable dilator blade
US11259737B2 (en) 2012-11-06 2022-03-01 Nuvasive, Inc. Systems and methods for performing neurophysiologic monitoring during spine surgery
US11877860B2 (en) 2012-11-06 2024-01-23 Nuvasive, Inc. Systems and methods for performing neurophysiologic monitoring during spine surgery
US9757067B1 (en) 2012-11-09 2017-09-12 Nuvasive, Inc. Systems and methods for performing neurophysiologic monitoring during spine surgery
US9757072B1 (en) 2013-02-11 2017-09-12 Nuvasive, Inc. Waveform marker placement algorithm for use in neurophysiologic monitoring
US11229789B2 (en) 2013-05-30 2022-01-25 Neurostim Oab, Inc. Neuro activator with controller
JP2016523125A (en) 2013-05-30 2016-08-08 グラハム エイチ. クリーシー Local nervous stimulation
FR3010628B1 (en) 2013-09-18 2015-10-16 Medicrea International METHOD FOR REALIZING THE IDEAL CURVATURE OF A ROD OF A VERTEBRAL OSTEOSYNTHESIS EQUIPMENT FOR STRENGTHENING THE VERTEBRAL COLUMN OF A PATIENT
FR3012030B1 (en) 2013-10-18 2015-12-25 Medicrea International METHOD FOR REALIZING THE IDEAL CURVATURE OF A ROD OF A VERTEBRAL OSTEOSYNTHESIS EQUIPMENT FOR STRENGTHENING THE VERTEBRAL COLUMN OF A PATIENT
US10258228B2 (en) 2014-08-08 2019-04-16 K2M, Inc. Retraction devices, systems, and methods for minimally invasive spinal surgery
US10420480B1 (en) 2014-09-16 2019-09-24 Nuvasive, Inc. Systems and methods for performing neurophysiologic monitoring
US11077301B2 (en) 2015-02-21 2021-08-03 NeurostimOAB, Inc. Topical nerve stimulator and sensor for bladder control
US10433793B1 (en) 2015-03-27 2019-10-08 Cadwell Laboratories, Inc. Methods and systems for simultaneous review of brain activity and physical manifestations of users
WO2017079655A2 (en) 2015-11-04 2017-05-11 Mcafee Paul C Methods and apparatus for spinal reconstructive surgery and measuring spinal length and intervertebral spacing, tension and rotation
US9801582B2 (en) * 2015-11-12 2017-10-31 King Saud University Thigh adhesion quantitative measurement system
WO2018109556A1 (en) 2016-12-12 2018-06-21 Medicrea International Systems and methods for patient-specific spinal implants
US11241297B2 (en) 2016-12-12 2022-02-08 Cadwell Laboratories, Inc. System and method for high density electrode management
JP7165668B2 (en) 2017-04-21 2022-11-04 メディクレア インターナショナル System for developing one or more patient-specific spinal implants
EP3706856A4 (en) 2017-11-07 2021-08-18 Neurostim Oab, Inc. Non-invasive nerve activator with adaptive circuit
US10918422B2 (en) 2017-12-01 2021-02-16 Medicrea International Method and apparatus for inhibiting proximal junctional failure
US11517239B2 (en) 2018-04-05 2022-12-06 Cadwell Laboratories, Inc. Systems and methods for processing and displaying electromyographic signals
US11596337B2 (en) 2018-04-24 2023-03-07 Cadwell Laboratories, Inc Methods and systems for operating an intraoperative neurophysiological monitoring system in conjunction with electrocautery procedures
US11185684B2 (en) 2018-09-18 2021-11-30 Cadwell Laboratories, Inc. Minimally invasive two-dimensional grid electrode
US11517245B2 (en) 2018-10-30 2022-12-06 Cadwell Laboratories, Inc. Method and system for data synchronization
EP3873336A1 (en) 2018-10-31 2021-09-08 Stryker Corporation System and method for monitoring nerve activity within a trachea of a patient
US11471087B2 (en) 2018-11-09 2022-10-18 Cadwell Laboratories, Inc. Integrity verification system for testing high channel count neuromonitoring recording equipment
US11317841B2 (en) 2018-11-14 2022-05-03 Cadwell Laboratories, Inc. Method and system for electrode verification
US11529107B2 (en) 2018-11-27 2022-12-20 Cadwell Laboratories, Inc. Methods for automatic generation of EEG montages
US11128076B2 (en) 2019-01-21 2021-09-21 Cadwell Laboratories, Inc. Connector receptacle
US11877801B2 (en) 2019-04-02 2024-01-23 Medicrea International Systems, methods, and devices for developing patient-specific spinal implants, treatments, operations, and/or procedures
US11925417B2 (en) 2019-04-02 2024-03-12 Medicrea International Systems, methods, and devices for developing patient-specific spinal implants, treatments, operations, and/or procedures
EP3990100A4 (en) 2019-06-26 2023-07-19 Neurostim Technologies LLC Non-invasive nerve activator with adaptive circuit
CA3152451A1 (en) 2019-12-16 2021-06-24 Michael Bernard Druke Non-invasive nerve activator with boosted charge delivery
US11769251B2 (en) 2019-12-26 2023-09-26 Medicrea International Systems and methods for medical image analysis

Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4795998A (en) * 1984-05-04 1989-01-03 Raychem Limited Sensor array
US5085226A (en) * 1990-05-30 1992-02-04 Trustees Of Boston University Force monitoring apparatus for back muscles
US5163328A (en) * 1990-08-06 1992-11-17 Colin Electronics Co., Ltd. Miniature pressure sensor and pressure sensor arrays
US5201325A (en) * 1989-09-01 1993-04-13 Andronic Devices Ltd. Advanced surgical retractor
US5253656A (en) * 1991-05-23 1993-10-19 Rincoe Richard G Apparatus and method for monitoring contact pressure between body parts and contact surfaces
US5924984A (en) * 1997-01-30 1999-07-20 University Of Iowa Research Foundation Anorectal probe apparatus having at least one muscular activity sensor
US20020194934A1 (en) * 2001-06-26 2002-12-26 Taylor Geoffrey L. Pressure measurement sensor with piezoresistive thread lattice
US6500210B1 (en) * 1992-09-08 2002-12-31 Seattle Systems, Inc. System and method for providing a sense of feel in a prosthetic or sensory impaired limb
WO2003005887A2 (en) * 2001-07-11 2003-01-23 Nuvasive, Inc. System and methods for determining nerve proximity, direction, and pathology during surgery
US6511427B1 (en) * 2000-03-10 2003-01-28 Acuson Corporation System and method for assessing body-tissue properties using a medical ultrasound transducer probe with a body-tissue parameter measurement mechanism
US20030212335A1 (en) * 2002-03-02 2003-11-13 Huang Herb H. Pulse diagnostic system
WO2003094744A1 (en) * 2002-05-09 2003-11-20 Tyco Healthcare Group Lp Endoscopic organ retractor and method of using the same
US20040068203A1 (en) * 2002-10-03 2004-04-08 Scimed Life Systems, Inc. Sensing pressure
US20040230131A1 (en) * 2003-02-21 2004-11-18 Kassab Ghassan S. System and method for measuring cross-sectional areas and pressure gradients in luminal organs

Family Cites Families (190)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2736002A (en) * 1956-02-21 oriel
US972983A (en) 1909-05-17 1910-10-18 Lester R Lantz Dilator.
US1328624A (en) * 1917-08-13 1920-01-20 Frank B Graham Dilator
US1548184A (en) 1923-04-11 1925-08-04 Will J Cameron Holder and control for pulp testers
US2704064A (en) * 1952-09-10 1955-03-15 Meditron Company Neurosurgical stimulator
US2808826A (en) 1956-01-19 1957-10-08 Teca Corp Electro-diagnostic apparatus and a circuit therefor
US3364929A (en) * 1964-12-21 1968-01-23 Burroughs Wellcome Co Method for administering muscle relaxant drug
US3682162A (en) 1968-12-13 1972-08-08 Wellcome Found Combined electrode and hypodermic syringe needle
US3664329A (en) * 1970-03-09 1972-05-23 Concept Nerve locator/stimulator
US3785368A (en) * 1971-08-23 1974-01-15 Carthy T Mc Abnormal nerve pressure locus detector and method
US3830226A (en) 1973-06-15 1974-08-20 Concept Variable output nerve locator
US3957036A (en) * 1975-02-03 1976-05-18 Baylor College Of Medicine Method and apparatus for recording activity in intact nerves
GB1534162A (en) * 1976-07-21 1978-11-29 Lloyd J Cyosurgical probe
US4099519A (en) * 1977-01-14 1978-07-11 Warren Fred E Diagnostic device
US4164214A (en) 1977-07-25 1979-08-14 The Regents Of The University Of California Method and apparatus for measuring the sensitivity of teeth
US4224949A (en) 1977-11-17 1980-09-30 Cornell Research Foundation, Inc. Method and electrical resistance probe for detection of estrus in bovine
US4226228A (en) 1978-11-02 1980-10-07 Shin Hee J Multiple joint retractor with light
US4235242A (en) 1979-04-02 1980-11-25 Med General, Inc. Electronic circuit permitting simultaneous use of stimulating and monitoring equipment
US4285347A (en) 1979-07-25 1981-08-25 Cordis Corporation Stabilized directional neural electrode lead
US4291705A (en) 1979-09-10 1981-09-29 The Regents Of The University Of California Neuromuscular block monitor
USRE34390E (en) 1980-12-31 1993-09-28 Nicolet Instrument Corporation Apparatus and method for topographic display of multichannel EEG data
US4461300A (en) * 1982-01-18 1984-07-24 Sutter Biomedical, Inc. Bone and tissue healing device including a special electrode assembly and method
US4592369A (en) * 1982-07-12 1986-06-03 National Research Development Corp. Method and apparatus for use in temporal analysis of waveforms
US4545374A (en) 1982-09-03 1985-10-08 Jacobson Robert E Method and instruments for performing a percutaneous lumbar diskectomy
US4519403A (en) * 1983-04-29 1985-05-28 Medtronic, Inc. Balloon lead and inflator
US4561445A (en) 1983-05-25 1985-12-31 Joseph J. Berke Elongated needle electrode and method of making same
FI73878C (en) * 1983-06-10 1987-12-10 Instrumentarium Oy FOERFARANDE FOER VIDAREUTVECKLING AV NERVMUSKELANSLUTNINGS MAETNING.
US4515168A (en) * 1983-07-22 1985-05-07 Chester Martin H Clamp-on nerve stimulator and locator
US4573448A (en) * 1983-10-05 1986-03-04 Pilling Co. Method for decompressing herniated intervertebral discs
US4562832A (en) * 1984-01-21 1986-01-07 Wilder Joseph R Medical instrument and light pipe illumination assembly
US4616660A (en) 1984-12-10 1986-10-14 Suncoast Medical Manufacturing, Inc. Variable alternating current output nerve locator/stimulator
US4633889A (en) * 1984-12-12 1987-01-06 Andrew Talalla Stimulation of cauda-equina spinal nerves
US4658835A (en) * 1985-07-25 1987-04-21 Cordis Corporation Neural stimulating lead with fixation canopy formation
WO1987001023A1 (en) * 1985-08-16 1987-02-26 David Brown Electromyographic repetitive strain injury monitor
US4892105A (en) * 1986-03-28 1990-01-09 The Cleveland Clinic Foundation Electrical stimulus probe
US4784150A (en) 1986-11-04 1988-11-15 Research Corporation Surgical retractor and blood flow monitor
US4759377A (en) 1986-11-26 1988-07-26 Regents Of The University Of Minnesota Apparatus and method for mechanical stimulation of nerves
US4744371A (en) * 1987-04-27 1988-05-17 Cordis Leads, Inc. Multi-conductor lead assembly for temporary use
US4926865A (en) * 1987-10-01 1990-05-22 Oman Paul S Microcomputer-based nerve and muscle stimulator
DE8803153U1 (en) * 1988-03-09 1988-06-23 B. Braun Melsungen Ag, 3508 Melsungen Catheter device for plexus anesthesia
US5772661A (en) * 1988-06-13 1998-06-30 Michelson; Gary Karlin Methods and instrumentation for the surgical correction of human thoracic and lumbar spinal disease from the antero-lateral aspect of the spine
US5015247A (en) * 1988-06-13 1991-05-14 Michelson Gary K Threaded spinal implant
US6770074B2 (en) 1988-06-13 2004-08-03 Gary Karlin Michelson Apparatus for use in inserting spinal implants
US5484437A (en) * 1988-06-13 1996-01-16 Michelson; Gary K. Apparatus and method of inserting spinal implants
US5127403A (en) 1988-07-05 1992-07-07 Cardiac Control Systems, Inc. Pacemaker catheter utilizing bipolar electrodes spaced in accordance to the length of a heart depolarization signal
US5058602A (en) 1988-09-30 1991-10-22 Brody Stanley R Paraspinal electromyography scanning
US4964411A (en) 1989-07-13 1990-10-23 Empi, Inc. Evoked EMG signal processing
US4962766A (en) 1989-07-19 1990-10-16 Herzon Garrett D Nerve locator and stimulator
US5125406A (en) * 1989-11-29 1992-06-30 Eet Limited Partnership (Del) Electrode endotracheal tube
US5454365A (en) * 1990-11-05 1995-10-03 Bonutti; Peter M. Mechanically expandable arthroscopic retractors
US5081990A (en) * 1990-05-11 1992-01-21 New York University Catheter for spinal epidural injection of drugs and measurement of evoked potentials
US5095905A (en) * 1990-06-07 1992-03-17 Medtronic, Inc. Implantable neural electrode
US5092344A (en) * 1990-11-19 1992-03-03 Lee Tzium Shou Remote indicator for stimulator
SE467561B (en) * 1990-12-04 1992-08-10 Dorsograf Ab DEVICE FOR SEATING TRANSPORT TIME OF NERV SIGNALS
US5480440A (en) * 1991-08-15 1996-01-02 Smith & Nephew Richards, Inc. Open surgical technique for vertebral fixation with subcutaneous fixators positioned between the skin and the lumbar fascia of a patient
US5161533A (en) 1991-09-19 1992-11-10 Xomed-Treace Inc. Break-apart needle electrode system for monitoring facial EMG
US5313962A (en) * 1991-10-18 1994-05-24 Obenchain Theodore G Method of performing laparoscopic lumbar discectomy
US5255691A (en) 1991-11-13 1993-10-26 Medtronic, Inc. Percutaneous epidural lead introducing system and method
US6500173B2 (en) 1992-01-07 2002-12-31 Ronald A. Underwood Methods for electrosurgical spine surgery
US5171279A (en) 1992-03-17 1992-12-15 Danek Medical Method for subcutaneous suprafascial pedicular internal fixation
US5284153A (en) * 1992-04-14 1994-02-08 Brigham And Women's Hospital Method for locating a nerve and for protecting nerves from injury during surgery
US5196015A (en) * 1992-04-30 1993-03-23 Neubardt Seth L Procedure for spinal pedicle screw insertion
US5474558A (en) 1992-04-30 1995-12-12 Neubardt; Seth L. Procedure and system for spinal pedicle screw insertion
US5312417A (en) * 1992-07-29 1994-05-17 Wilk Peter J Laparoscopic cannula assembly and associated method
US5299563A (en) * 1992-07-31 1994-04-05 Seton Joseph Z Method of using a surgical retractor
US5772597A (en) 1992-09-14 1998-06-30 Sextant Medical Corporation Surgical tool end effector
EP0719113A1 (en) * 1992-11-13 1996-07-03 American Cardiac Ablation Co., Inc. Fluid cooled electrosurgical probe
US5375067A (en) 1992-12-11 1994-12-20 Nicolet Instrument Corporation Method and apparatus for adjustment of acquisition parameters in a data acquisition system such as a digital oscilloscope
US5814073A (en) 1996-12-13 1998-09-29 Bonutti; Peter M. Method and apparatus for positioning a suture anchor
US5327902A (en) 1993-05-14 1994-07-12 Lemmen Roger D Apparatus for use in nerve conduction studies
US5333618A (en) 1993-06-30 1994-08-02 Gregory Lekhtman Portable self-contained instrument for the measurement of nerve resistance of a patient
US5549656A (en) 1993-08-16 1996-08-27 Med Serve Group, Inc. Combination neuromuscular stimulator and electromyograph system
US5566678B1 (en) 1993-09-10 1999-11-30 Cadwell Ind Inc Digital eeg noise synthesizer
US5560372A (en) 1994-02-02 1996-10-01 Cory; Philip C. Non-invasive, peripheral nerve mapping device and method of use
CA2144211C (en) * 1994-03-16 2005-05-24 David T. Green Surgical instruments useful for endoscopic spinal procedures
CA2551185C (en) 1994-03-28 2007-10-30 Sdgi Holdings, Inc. Apparatus and method for anterior spinal stabilization
US5575284A (en) * 1994-04-01 1996-11-19 University Of South Florida Portable pulse oximeter
US5482038A (en) * 1994-06-28 1996-01-09 Cadwell Industries, Inc. Needle electrode assembly
US5593429A (en) * 1994-06-28 1997-01-14 Cadwell Industries, Inc. Needle electrode with depth of penetration limiter
US5540235A (en) 1994-06-30 1996-07-30 Wilson; John R. Adaptor for neurophysiological monitoring with a personal computer
US6038469A (en) * 1994-10-07 2000-03-14 Ortivus Ab Myocardial ischemia and infarction analysis and monitoring method and apparatus
US5579781A (en) 1994-10-13 1996-12-03 Cooke; Thomas H. Wireless transmitter for needle electrodes as used in electromyography
US5630813A (en) * 1994-12-08 1997-05-20 Kieturakis; Maciej J. Electro-cauterizing dissector and method for facilitating breast implant procedure
US5601608A (en) * 1995-02-02 1997-02-11 Pacesetter, Inc. Methods and apparatus for applying charge-balanced antiarrhythmia shocks
US5860973A (en) * 1995-02-27 1999-01-19 Michelson; Gary Karlin Translateral spinal implant
US5671752A (en) 1995-03-31 1997-09-30 Universite De Montreal/The Royal Insitution For The Advancement Of Learning (Mcgill University) Diaphragm electromyography analysis method and system
WO1996032156A1 (en) 1995-04-10 1996-10-17 St. Luke's-Roosevelt Hospital Peripheral nerve stimulation device for unassisted nerve blockade
US5711307A (en) * 1995-04-13 1998-01-27 Liberty Mutual Insurance Company Method and apparatus for detecting myoelectric activity from the surface of the skin
US5775331A (en) 1995-06-07 1998-07-07 Uromed Corporation Apparatus and method for locating a nerve
DE29510204U1 (en) * 1995-06-23 1995-08-31 Aesculap Ag, 78532 Tuttlingen Surgical retractor
US5797854A (en) 1995-08-01 1998-08-25 Hedgecock; James L. Method and apparatus for testing and measuring current perception threshold and motor nerve junction performance
DE19530869A1 (en) 1995-08-22 1997-02-27 Sterimed Gmbh Puncturing and / or catheterizing device for probing nerves
US5769781A (en) * 1995-11-13 1998-06-23 Chappuis; James L. Protector retractor
US5707359A (en) * 1995-11-14 1998-01-13 Bufalini; Bruno Expanding trocar assembly
US6425901B1 (en) 1995-12-07 2002-07-30 Loma Linda University Medical Center Vascular wound closure system
US5779642A (en) 1996-01-16 1998-07-14 Nightengale; Christopher Interrogation device and method
US5792044A (en) 1996-03-22 1998-08-11 Danek Medical, Inc. Devices and methods for percutaneous surgery
DE19618945C2 (en) 1996-05-10 2003-02-27 Phonak Ag Staefa Fixable positioning system for a firm, play-free connection to the human skull
US5853373A (en) 1996-08-05 1998-12-29 Becton, Dickinson And Company Bi-level charge pulse apparatus to facilitate nerve location during peripheral nerve block procedures
US5759159A (en) * 1996-09-25 1998-06-02 Ormco Corporation Method and apparatus for apical detection with complex impedance measurement
US5862314A (en) * 1996-11-01 1999-01-19 Micron Electronics, Inc. System and method for remapping defective memory locations
US6135965A (en) 1996-12-02 2000-10-24 Board Of Regents, The University Of Texas System Spectroscopic detection of cervical pre-cancer using radial basis function networks
BR9604655C1 (en) * 1996-12-05 1999-12-28 Waldir Teixeira Reno Grid retractor for surgery.
US6119068A (en) 1996-12-27 2000-09-12 Kannonji; Michihiro Rear-end collision alarming device and method linked to speed control device of a vehicle
US5928158A (en) 1997-03-25 1999-07-27 Aristides; Arellano Medical instrument with nerve sensor
US6050992A (en) * 1997-05-19 2000-04-18 Radiotherapeutics Corporation Apparatus and method for treating tissue with multiple electrodes
US6132387A (en) 1997-07-01 2000-10-17 Neurometrix, Inc. Neuromuscular electrode
US6146335A (en) 1997-07-01 2000-11-14 Neurometrix, Inc. Apparatus for methods for the assessment of neuromuscular function of the lower extremity
US6132386A (en) 1997-07-01 2000-10-17 Neurometrix, Inc. Methods for the assessment of neuromuscular function by F-wave latency
US5851191A (en) 1997-07-01 1998-12-22 Neurometrix, Inc. Apparatus and methods for assessment of neuromuscular function
US5872314A (en) * 1997-07-25 1999-02-16 Clinton; Robert P. Method and apparatus for measuring characteristics of meat
US6348058B1 (en) * 1997-12-12 2002-02-19 Surgical Navigation Technologies, Inc. Image guided spinal surgery guide, system, and method for use thereof
US6306100B1 (en) 1997-12-16 2001-10-23 Richard L. Prass Intraoperative neurophysiological monitoring system
US6181961B1 (en) * 1997-12-16 2001-01-30 Richard L. Prass Method and apparatus for an automatic setup of a multi-channel nerve integrity monitoring system
US6206826B1 (en) * 1997-12-18 2001-03-27 Sdgi Holdings, Inc. Devices and methods for percutaneous surgery
US5928139A (en) 1998-04-24 1999-07-27 Koros; Tibor B. Retractor with adjustable length blades and light pipe guides
US6161047A (en) 1998-04-30 2000-12-12 Medtronic Inc. Apparatus and method for expanding a stimulation lead body in situ
US6004262A (en) 1998-05-04 1999-12-21 Ad-Tech Medical Instrument Corp. Visually-positioned electrical monitoring apparatus
US6139493A (en) 1998-07-08 2000-10-31 Koros; Tibor B. Retractor with adjustable length blades and light pipe guides
US6027456A (en) * 1998-07-10 2000-02-22 Advanced Neuromodulation Systems, Inc. Apparatus and method for positioning spinal cord stimulation leads
JP2000028717A (en) 1998-07-13 2000-01-28 Mitsubishi Electric Corp Device for detecting obstacle
US6104960A (en) 1998-07-13 2000-08-15 Medtronic, Inc. System and method for providing medical electrical stimulation to a portion of the nervous system
US6126660A (en) 1998-07-29 2000-10-03 Sofamor Danek Holdings, Inc. Spinal compression and distraction devices and surgical methods
US6366813B1 (en) 1998-08-05 2002-04-02 Dilorenzo Daniel J. Apparatus and method for closed-loop intracranical stimulation for optimal control of neurological disease
US6292701B1 (en) 1998-08-12 2001-09-18 Medtronic Xomed, Inc. Bipolar electrical stimulus probe with planar electrodes
US6104957A (en) 1998-08-21 2000-08-15 Alo; Kenneth M. Epidural nerve root stimulation with lead placement method
US6139545A (en) 1998-09-09 2000-10-31 Vidaderm Systems and methods for ablating discrete motor nerve regions
US6038477A (en) * 1998-12-23 2000-03-14 Axon Engineering, Inc. Multiple channel nerve stimulator with channel isolation
JP4430238B2 (en) 1998-09-18 2010-03-10 英博 山本 Endoscope electrification device
US6451015B1 (en) 1998-11-18 2002-09-17 Sherwood Services Ag Method and system for menu-driven two-dimensional display lesion generator
US6507755B1 (en) * 1998-12-01 2003-01-14 Neurometrix, Inc. Apparatus and method for stimulating human tissue
US6266558B1 (en) 1998-12-01 2001-07-24 Neurometrix, Inc. Apparatus and method for nerve conduction measurements with automatic setting of stimulus intensity
US6564078B1 (en) * 1998-12-23 2003-05-13 Nuvasive, Inc. Nerve surveillance cannula systems
ATE306213T1 (en) 1998-12-23 2005-10-15 Nuvasive Inc DEVICES FOR CANNULATION AND NERVE MONITORING
US6393325B1 (en) * 1999-01-07 2002-05-21 Advanced Bionics Corporation Directional programming for implantable electrode arrays
US6312451B1 (en) 1999-03-23 2001-11-06 Jackson Streeter Low level laser therapy apparatus
US6074343A (en) * 1999-04-16 2000-06-13 Nathanson; Michael Surgical tissue retractor
US6224549B1 (en) * 1999-04-20 2001-05-01 Nicolet Biomedical, Inc. Medical signal monitoring and display
US6259945B1 (en) * 1999-04-30 2001-07-10 Uromed Corporation Method and device for locating a nerve
US6901928B2 (en) 1999-05-04 2005-06-07 Paul G. Loubser Superglottic and peri-laryngeal apparatus for supraglottic airway insertion
DE29908259U1 (en) 1999-05-07 1999-07-15 Aesculap AG & Co. KG, 78532 Tuttlingen Rotating surgical tool
ES2270814T3 (en) * 1999-05-07 2007-04-16 AESCULAP AG & CO. KG ROTATING SURGICAL TOOL.
FR2795624B1 (en) 1999-07-01 2001-09-28 Vanacker Gerard METHOD FOR DRILLING THE VERTEBRAL PEDICLE, PARTICULARLY FOR THE PLACEMENT OF A PEDICULAR SCREW, AN INSTRUMENT FOR THE IMPLEMENTATION OF SUCH A PROCESS
FR2796846A1 (en) 1999-07-30 2001-02-02 Mohamed Zouheir Naja Thoraco-abdominal or pelvic anaesthesia apparatus comprises needle and electrode linked to electrical power source, extension, guide tube and catheter
US6334068B1 (en) 1999-09-14 2001-12-25 Medtronic Xomed, Inc. Intraoperative neuroelectrophysiological monitor
US6546271B1 (en) * 1999-10-01 2003-04-08 Bioscience, Inc. Vascular reconstruction
US20050256582A1 (en) 1999-10-08 2005-11-17 Ferree Bret A Spinal implants, including devices that reduce pressure on the annulus fibrosis
US6500180B1 (en) * 1999-10-20 2002-12-31 Sdgi Holdings, Inc. Methods and instrumentation for distraction of a disc space
JP4854900B2 (en) 1999-11-24 2012-01-18 ヌバシブ, インコーポレイテッド EMG measurement method
US6466817B1 (en) 1999-11-24 2002-10-15 Nuvasive, Inc. Nerve proximity and status detection system and method
US6582441B1 (en) * 2000-02-24 2003-06-24 Advanced Bionics Corporation Surgical insertion tool
US6312392B1 (en) 2000-04-06 2001-11-06 Garrett D. Herzon Bipolar handheld nerve locator and evaluator
WO2001087154A1 (en) * 2000-05-18 2001-11-22 Nuvasive, Inc. Tissue discrimination and applications in medical procedures
AU6976801A (en) * 2000-06-08 2001-12-17 Nuvasive Inc Relative nerve movement and status detection system and method
WO2002013714A1 (en) * 2000-08-17 2002-02-21 Image Guided Neurologies, Inc. Trajectory guide with instrument immobilizer
US6487446B1 (en) 2000-09-26 2002-11-26 Medtronic, Inc. Method and system for spinal cord stimulation prior to and during a medical procedure
US7089059B1 (en) 2000-11-03 2006-08-08 Pless Benjamin D Predicting susceptibility to neurological dysfunction based on measured neural electrophysiology
US6847849B2 (en) * 2000-11-15 2005-01-25 Medtronic, Inc. Minimally invasive apparatus for implanting a sacral stimulation lead
US20080039914A1 (en) 2000-11-24 2008-02-14 Nervonix, Inc. Needle with depth determination capability and method of use
US6346078B1 (en) * 2000-12-04 2002-02-12 Alan G. Ellman Eyelid retractor for electrosurgery
US6618626B2 (en) 2001-01-16 2003-09-09 Hs West Investments, Llc Apparatus and methods for protecting the axillary nerve during thermal capsullorhaphy
US6929606B2 (en) 2001-01-29 2005-08-16 Depuy Spine, Inc. Retractor and method for spinal pedicle screw placement
US6839594B2 (en) 2001-04-26 2005-01-04 Biocontrol Medical Ltd Actuation and control of limbs through motor nerve stimulation
US20030105503A1 (en) * 2001-06-08 2003-06-05 Nuvasive, Inc. Relative nerve movement and status detection system and method
US6855105B2 (en) * 2001-07-11 2005-02-15 Jackson, Iii Avery M. Endoscopic pedicle probe
US6926728B2 (en) 2001-07-18 2005-08-09 St. Francis Medical Technologies, Inc. Curved dilator and method
EP1435828A4 (en) * 2001-09-25 2009-11-11 Nuvasive Inc System and methods for performing surgical procedures and assessments
US20030078618A1 (en) 2001-10-19 2003-04-24 Fey Kate E. System and method for removing implanted devices
EP1443859A4 (en) * 2001-10-24 2006-03-22 Cutting Edge Surgical Inc Intraosteal ultrasound during surgical implantation
US7664544B2 (en) * 2002-10-30 2010-02-16 Nuvasive, Inc. System and methods for performing percutaneous pedicle integrity assessments
US6916330B2 (en) * 2001-10-30 2005-07-12 Depuy Spine, Inc. Non cannulated dilators
US7824410B2 (en) 2001-10-30 2010-11-02 Depuy Spine, Inc. Instruments and methods for minimally invasive spine surgery
US7214197B2 (en) 2001-11-06 2007-05-08 Prass Richard L Intraoperative neurophysiological monitoring system
US6730021B2 (en) * 2001-11-07 2004-05-04 Computer Motion, Inc. Tissue spreader with force measurement, force indication or force limitation
FR2835732B1 (en) 2002-02-11 2004-11-12 Spinevision DEVICE FOR TRACKING THE PENETRATION OF A PENETRATION MEANS IN ANATOMICAL ELEMENTS
US7294127B2 (en) 2002-03-05 2007-11-13 Baylis Medical Company Inc. Electrosurgical tissue treatment method
US7258688B1 (en) 2002-04-16 2007-08-21 Baylis Medical Company Inc. Computerized electrical signal generator
US8147421B2 (en) * 2003-01-15 2012-04-03 Nuvasive, Inc. System and methods for determining nerve direction to a surgical instrument
US7153279B2 (en) 2002-07-09 2006-12-26 George Washington University Brain retraction sensor
US6916294B2 (en) 2002-07-09 2005-07-12 George Washington University Brain retraction sensor
AU2002950769A0 (en) 2002-08-06 2002-09-12 Neopraxis Pty Ltd A method and system for inserting an electrode
US7282033B2 (en) 2002-09-04 2007-10-16 Urmey William F Positioning system for a nerve stimulator needle
US8137284B2 (en) * 2002-10-08 2012-03-20 Nuvasive, Inc. Surgical access system and related methods
US20040225228A1 (en) * 2003-05-08 2004-11-11 Ferree Bret A. Neurophysiological apparatus and procedures
AU2004263152B2 (en) * 2003-08-05 2009-08-27 Nuvasive, Inc. Systems and methods for performing dynamic pedicle integrity assessments
EP1680177B1 (en) 2003-09-25 2017-04-12 NuVasive, Inc. Surgical access system
WO2006012535A1 (en) 2004-07-23 2006-02-02 North Carolina State University Force-determining retraction device and associated method
US20060052856A1 (en) * 2004-09-08 2006-03-09 Kim Daniel H Stimulation components
EP2409641B1 (en) 2005-02-02 2017-07-05 NuVasive, Inc. System for performing neurophysiologic assessments during spine surgery
USD574955S1 (en) 2007-06-22 2008-08-12 Vioptix, Inc. Portion of nerve root retractor with sensor

Patent Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4795998A (en) * 1984-05-04 1989-01-03 Raychem Limited Sensor array
US5201325A (en) * 1989-09-01 1993-04-13 Andronic Devices Ltd. Advanced surgical retractor
US5085226A (en) * 1990-05-30 1992-02-04 Trustees Of Boston University Force monitoring apparatus for back muscles
US5163328A (en) * 1990-08-06 1992-11-17 Colin Electronics Co., Ltd. Miniature pressure sensor and pressure sensor arrays
US5253656A (en) * 1991-05-23 1993-10-19 Rincoe Richard G Apparatus and method for monitoring contact pressure between body parts and contact surfaces
US6500210B1 (en) * 1992-09-08 2002-12-31 Seattle Systems, Inc. System and method for providing a sense of feel in a prosthetic or sensory impaired limb
US5924984A (en) * 1997-01-30 1999-07-20 University Of Iowa Research Foundation Anorectal probe apparatus having at least one muscular activity sensor
US6511427B1 (en) * 2000-03-10 2003-01-28 Acuson Corporation System and method for assessing body-tissue properties using a medical ultrasound transducer probe with a body-tissue parameter measurement mechanism
US20020194934A1 (en) * 2001-06-26 2002-12-26 Taylor Geoffrey L. Pressure measurement sensor with piezoresistive thread lattice
WO2003005887A2 (en) * 2001-07-11 2003-01-23 Nuvasive, Inc. System and methods for determining nerve proximity, direction, and pathology during surgery
US20030212335A1 (en) * 2002-03-02 2003-11-13 Huang Herb H. Pulse diagnostic system
WO2003094744A1 (en) * 2002-05-09 2003-11-20 Tyco Healthcare Group Lp Endoscopic organ retractor and method of using the same
US20040068203A1 (en) * 2002-10-03 2004-04-08 Scimed Life Systems, Inc. Sensing pressure
US20040230131A1 (en) * 2003-02-21 2004-11-18 Kassab Ghassan S. System and method for measuring cross-sectional areas and pressure gradients in luminal organs

Cited By (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11026627B2 (en) 2013-03-15 2021-06-08 Cadwell Laboratories, Inc. Surgical instruments for determining a location of a nerve during a procedure
US11963784B2 (en) 2013-11-07 2024-04-23 Safeop Surgical, Inc. Systems and methods for detecting nerve function
US10092762B2 (en) 2014-08-15 2018-10-09 Axonics Modulation Technologies, Inc. Integrated electromyographic clinician programmer for use with an implantable neurostimulator
US9555246B2 (en) 2014-08-15 2017-01-31 Axonics Modulation Technologies, Inc. Electromyographic lead positioning and stimulation titration in a nerve stimulation system for treatment of overactive bladder
US11730411B2 (en) 2014-08-15 2023-08-22 Axonics, Inc. Methods for determining neurostimulation electrode configurations based on neural localization
US10406369B2 (en) 2014-08-15 2019-09-10 Axonics Modulation Technologies, Inc. Electromyographic lead positioning and stimulation titration in a nerve stimulation system for treatment of overactive bladder
US10729903B2 (en) 2014-08-15 2020-08-04 Axonics Modulation Technologies, Inc. Methods for determining neurostimulation electrode configurations based on neural localization
US9561372B2 (en) 2014-08-15 2017-02-07 Axonics Modulation Technologies, Inc. Electromyographic lead positioning and stimulation titration in a nerve stimulation system for treatment of overactive bladder
US11116985B2 (en) 2014-08-15 2021-09-14 Axonics, Inc. Clinician programmer for use with an implantable neurostimulation lead
US9533155B2 (en) 2014-08-15 2017-01-03 Axonics Modulation Technologies, Inc. Methods for determining neurostimulation electrode configurations based on neural localization
US11497916B2 (en) 2014-08-15 2022-11-15 Axonics, Inc. Electromyographic lead positioning and stimulation titration in a nerve stimulation system for treatment of overactive bladder
US9855423B2 (en) 2014-08-15 2018-01-02 Axonics Modulation Technologies, Inc. Systems and methods for neurostimulation electrode configurations based on neural localization
US12048567B2 (en) 2015-05-04 2024-07-30 Safeop Surgical, Inc. System, method, and computer algorithm for measuring, displaying, and accurately detecting changes in electrophysiological evoked potentials
US11986321B2 (en) 2016-09-22 2024-05-21 Safeop Surgical, Inc. System and method for detecting and removing periodic non-physiological artifact from evoked potentials
US11177610B2 (en) 2017-01-23 2021-11-16 Cadwell Laboratories, ino. Neuromonitoring connection system
US11949188B2 (en) 2017-01-23 2024-04-02 Cadwell Laboratories, Inc. Methods for concurrently forming multiple electrical connections in a neuro-monitoring system
US11963775B2 (en) 2017-03-22 2024-04-23 Safeop Surgical, Inc. Medical systems and methods for detecting changes in electrophysiological evoked potentials
US11701047B2 (en) 2017-06-16 2023-07-18 Alphatec Spine, Inc. Systems, methods, and devices for detecting the threshold of nerve-muscle response using variable frequency of stimulation
US11992339B2 (en) 2018-05-04 2024-05-28 Cadwell Laboratories, Inc. Systems and methods for dynamic neurophysiological stimulation
US11998338B2 (en) 2018-05-04 2024-06-04 Cadwell Laboratories, Inc. Systems and methods for dynamically switching output port cathode and anode designations
US11253182B2 (en) 2018-05-04 2022-02-22 Cadwell Laboratories, Inc. Apparatus and method for polyphasic multi-output constant-current and constant-voltage neurophysiological stimulation
US11443649B2 (en) 2018-06-29 2022-09-13 Cadwell Laboratories, Inc. Neurophysiological monitoring training simulator
US11978360B2 (en) 2018-06-29 2024-05-07 Cadwell Laboratories, Inc. Systems and methods for neurophysiological simulation
US11848090B2 (en) 2019-05-24 2023-12-19 Axonics, Inc. Trainer for a neurostimulator programmer and associated methods of use with a neurostimulation system
US11439829B2 (en) 2019-05-24 2022-09-13 Axonics, Inc. Clinician programmer methods and systems for maintaining target operating temperatures

Also Published As

Publication number Publication date
US20100317989A1 (en) 2010-12-16
US20070021682A1 (en) 2007-01-25
US8740783B2 (en) 2014-06-03

Similar Documents

Publication Publication Date Title
US8740783B2 (en) System and methods for performing neurophysiologic assessments with pressure monitoring
US11617562B2 (en) System and methods for nerve monitoring
US11793447B2 (en) System and methods for performing neurophysiologic assessments during spine surgery
US10507120B2 (en) Systems and methods for performing surgical procedures and assessments
US8989866B2 (en) System and methods for assessing the neuromuscular pathway prior to nerve testing
US12127877B2 (en) System and methods for nerve monitoring

Legal Events

Date Code Title Description
AS Assignment

Owner name: NUVASIVE, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:GHARIB, JAMES;FARQUHAR, ALLEN;MARTINELLI, SCOT;AND OTHERS;SIGNING DATES FROM 20101011 TO 20101020;REEL/FRAME:033015/0649

AS Assignment

Owner name: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT, CALIFORNIA

Free format text: NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS;ASSIGNORS:NUVASIVE, INC.;IMPULSE MONITORING, INC.;REEL/FRAME:040634/0404

Effective date: 20160208

Owner name: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT, CA

Free format text: NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS;ASSIGNORS:NUVASIVE, INC.;IMPULSE MONITORING, INC.;REEL/FRAME:040634/0404

Effective date: 20160208

AS Assignment

Owner name: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT, TE

Free format text: NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS;ASSIGNORS:NUVASIVE, INC.;BIOTRONIC NATIONAL, LLC;NUVASIVE CLINICAL SERVICES MONITORING, INC.;AND OTHERS;REEL/FRAME:042490/0236

Effective date: 20170425

Owner name: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT, TEXAS

Free format text: NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS;ASSIGNORS:NUVASIVE, INC.;BIOTRONIC NATIONAL, LLC;NUVASIVE CLINICAL SERVICES MONITORING, INC.;AND OTHERS;REEL/FRAME:042490/0236

Effective date: 20170425

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

AS Assignment

Owner name: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT, NORTH CAROLINA

Free format text: SECURITY INTEREST;ASSIGNORS:NUVASIVE, INC.;NUVASIVE CLINICAL SERVICES MONITORING, INC.;NUVASIVE CLINICAL SERVICES, INC.;AND OTHERS;REEL/FRAME:052918/0595

Effective date: 20200224